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In a murine model of Leishmania major infection, susceptible BALB/c mice develop a  
detrimental Type 2 immune response characterized by the production of interleukin (IL)-4 and 
IL-13, which single through a common receptor, the IL-4 receptor alpha chain (IL-4R⍺). 
Forkhead box P3 (Foxp3+) Regulatory T (Treg) cells are an unique subset of CD4+ T cells that 
play important immunomodulatory roles maintaining a balance between Type 1 and Type 2 
immune responses. During L. major induced cutaneous leishmaniasis, Treg cells accumulation 
at the site of infection has been implicated in suppressing a detrimental Type 2 immune 
response by modulating early interleukin (IL)-4 production, however it remains unclear if IL-
4Rα mediated signalling on Treg cells play a significant role in this process. To investigate this 
further, a novel BALB/c model was utilized in which the IL-4Rα chain was conditionally 
knocked out on Treg cells (Foxp3creIL-4Rα-/lox mice). We demonstrated that the differential IL-
4Rα deletion efficiency in male (approximately 102 %) and female (approximately 32%) was 
maintained during L. major infection. Foxp3creIL-4Rα-/lox male mice, which had a greater 
degree of IL-4Rα deletion on Foxp3+ Treg cells, developed significant footpad swellings and 
ear swellings, increased parasitic burdens at the site of infection and within draining lymph 
nodes. This hypersusceptible phenotype observed in Foxp3creIL-4Rα-/lox BALB/c male mice 
was accompanied with an increased Treg cell activity and amplified Type-2 immune response 
with an increase in IL-4, IL-10 from L. major-infected lymph node samples and IgE antibody 
secretion in L. major infected serum samples. Flow cytometry analysis revealed that a L. major- 
induced Indoleamine 2,3 dioxygenase (IDO)-mechanism could allow for increased Leishmania 
replication. Collectively, these data suggest a protective role for IL-4Rα signalling on Treg 













Leishmaniasis is a highly prevalent vector-borne tropical disease, that is caused by parasites of 
the Leishmania genus and is transmitted to mammalian hosts by the bite of infected female 
sandflies (Phlebotomus, Lutzymia) [1, 2]. Globally, approximately 1.6 million new cases and 
65000 deaths are estimated to occur annually and 1 billion people remain at risk of Leishmania 
infection [3]. Despite this high rate of morbidity and mortality, leishmaniasis is regarded as a 
disease of poverty as the majority of those affected are in less developed countries in South 
East Asia, Africa and South America [4]. The effects of urbanisation, deforestation and armed 
conflict have limited the diversity of mammalian hosts from which sandflies can take a blood 
meal, thus increasing the transmission to humans [5]. 
 
The disease exists as three main clinical manifestations. Cutaneous leishmaniasis, caused by 
L. major, L. tropica and  L. mexicana, is the most prevalent form of the disease, as outlined in 
Table 1, leading to 1.2 million new infections annually and is characterised by the formation 
of disfiguring cutaneous lesions [2, 3, 6]. Mucocutaneous leishmaniasis, caused by L. 
brazilensis parasites, result in ulcer formation and destruction of the mucus membranes within 
the nose and mouse [7]. Visceral leishmaniasis, caused by L. infantum and L. donovani 
parasites, was prevalent in South East Asia, Africa, Eastern Mediterranean and the Americas 
(Table 1)  and causes lethality if left untreated as parasites disseminate through the bloodstream 
and invade internal organs [3, 8].  
 
Table 1.1: The number of reported cases of cutaneous leishmaniasis and visceral leishmaniasis 
in 2017 (WHO 2019) [3]  
 
Region  Cutaneous leishmaniasis cases in 2017 
Visceral leishmaniasis cases in 
2017 
Africa  13951 6050 




Europe 1056 180 
South East Asia 3 6176 




1.2 Lifecycle of Leishmania parasites 
 
 Leishmania parasites have a digenetic lifecycle existing as flagellated promastigotes within 
the mid-gut of the infected sandfly and aflagellated amastigotes within the mammalian host 
[9].  Upon taking up of a blood meal by an infected sandfly, the promastigotes present within 
the microvilli of the midgut epithelium are ejected through the proboscis into the mammalian 
host [10]. Once within the mammalian host, promastigotes are subsequently phagocytosed by 
several antigen-presenting cells (APCs) including dendritic cells, macrophages and 
neutrophils. Leishmania promastigotes are able to overcome the microbicidal activity of the 
phagosome, preventing the formation of the phagolysosome, resulting in the formation of a 
parasitophorous vacuole [11]. The opportune conditions within the parasitophorous vacuole 
allow promastigotes to differentiate into amastigotes, which continue to replicate and upon 
cellular apoptosis are released to infect surrounding immune cells thus leading to the 
establishment of infection. 
 
1.3 Diagnosis and current treatment of cutaneous leishmaniasis 
 
The incidence of cutaneous leishmaniasis in human patients remains underreported as the 
development of a lesion may only occur after two weeks to three months post infection, 
therefore early disease diagnosis remains poor [12]. The disease is primarily diagnosed using 
parasitological techniques to detect amastigotes from biopsy specimen under a light 
microscope or immunohistochemistry [13]. However, the limitations of such techniques are 
that they have relatively low sensitivities , resulting in many Leishmania infections being 
misdiagnosed. 
 
Consequently, molecular based methods have been utilised to amplify different target regions 
in Leishmania DNA. Different primer sequences to target repetitive Leishmania kinetoplast 
DNA (kDNA) or small subunit ribosomal RNA (SSU rRNA) via PCR have allowed for highly 
sensitive parasite detection as well as the identification of the particular Leishmania species in 
infected patients [13, 14].  
 
There are currently no approved vaccines commercially available to prevent against cutaneous 
leishmaniasis and the front-line drug therapies available to reduce lesions include pentavalent 
antimonials, liposomal amphotericin B and miltefosine which target the Leishmania parasite 
[15]. Miltefosine treatment administered orally at a dose of 2mg/kg for 28 days has been shown 
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to have a 60-90% effectiveness rate [15]. Liposomal Amphoterin B deoxycholate 
administration intravenously at a dose of 25mg/kg significantly reduced lesion sizes following 
six days of treatment [16]. Pentavalent antimonials, such as Pentostam, are administered 
intramuscularly for a 20-day course at a dose of 20mg/kg/day; such compounds have a 90% 
effectiveness rate as they inhibit parasitic glycolysis and fatty acid oxidation [16]. However 
this drug treatment options have negative side effects associated which include cardiotoxicity, 
renal toxicity and nausea, and an increasing emergence of drug-resistant Leishmania 
populations [17, 18], therefore there remains a crucial need to understand the interaction 
between Leishmania parasites and their mammalian hosts to identify novel immunotherapeutic 
targets for effective disease management. 
 
1.4  Use of murine models to understand immune polarization during cutaneous 
leishmaniasis 
 
The introduction of L. major promastigotes into experimental mouse models has provided a 
robust model to investigate the immune evasion strategies utilized by Leishmania parasites, as 
well as immune response elicited in mammalian hosts during cutaneous leishmaniasis. BALB/c 
mice during L. major infection, display a susceptible phenotype that is characterized by parasite 
persistence and lesion development [19]. In contrast, C57BL/6 mice following 8 weeks of L. 
major infection, displayed a resistant phenotype showing a significant reduction in lesion size 
[20].  
 
The resistant phenotype observed in C57BL/6 mice led to the in vivo characterization of a Type 
1 immune response, defined by a reduction in IgG1 and IgE antibody serum levels and 
increased IgG2b and IgG3 antibodies. Interferon-gamma (IFN-g) and IL-12 have been shown 
to directly enhance T helper 1 (Th1) cell development in vitro and in vivo, which are required 
for the resistant phenotype observed during L. major infection [21, 22]. Th1 cells, through the 
secretion of tumour necrosis factor (TNF), IL-12 and IFN-g, activate the production of 
classically activated (M1) macrophages. M1 macrophages primarily regulate killing effector 
mechanisms through secretion of reactive oxygen species such as hydrogen peroxide (H2O2) 
and reactive nitrogen species intermediates such as nitric oxide (NO) that lead to the destruction 
of intracellular Leishmania parasites [11, 23]. 
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In contrast, susceptibility to L. major infection observed in BALB/c mice has been attributed 
to the activation of Type 2 immune response. During a Type 2 immune response, IL-4 and IL-
13 secretion have been shown to polarize naïve T cells towards Th2 cell development and 
directly inhibit IFN-g production by Th1 cells. Th2 cells secretion of IL-4, IL-13 and IL-10, 
leads to the activation of alternatively activated (M2) macrophages that secrete arginase 1. 
Arginase 1 (Arg1) secretion depletes the common L-arginine substrate, that is required by 
induced nitric oxide synthase (iNOS) for NO production; this leads to an inhibition of M1 
macrophage activation and a reduction in a Type 1 immune response. L. major parasites are 
able to evade the killing-effector mechanisms of M1 macrophages, by enhancing IL-4 and IL-
13 secretion, leading to M2 macrophage activation thereby enabling sustained intracellular 
replication [11, 24]. The Type 2 immune response in infected BALB/c mice further differs 
from a Type 1 immune response, as higher levels of IgE and IgG1 serum antibodies have been 
reported [25]. 
1.5 IL-4, IL-13 and the role of IL-4Rα chain 
1.5.1 Defining the role of IL-4 and IL-13 during cutaneous leishmaniasis 
Murine IL-4 and IL-13 have been identified as canonical cytokines that maintain Type 2 
immune response, observed in susceptible BALB/c mice during L. major infection. IL-4 has a 
molecular weight of 14-19 kDA and IL-13 has a molecular weight of 10-14 kDA and both are 
localised on chromosome 11 [26]. Although IL-4 and IL-13 are key immunoregulatory 
cytokines required for the initiation of a Type 2 immune response, they are initially secreted in 
both BALB/c mice and C57BL/6 mice during the early stages of infection [27, 28]. Various 
immune cells have been identified as producers of IL-4 and IL-13 such as innate immune cells 
including dendritic cells, basophils, natural killer T cells, mast cells and adaptive immune cells 
including Th2 cells and B effector 2 (Be2) B cells [26]. 
Despite this early IL-4 production in both strains, IL-4 signalling is short-lived in resistant 
C57BL/6 mice and is sustained in susceptible BALB/c mice [28]. The observed differences in 
IL-4 signalling between the two different strains of mice, led to the emergence of research 
centred around establishing a mechanism that could explain the contrasting disease phenotypes 
observed. 
IL-13 signalling is critical for enhancing susceptibility during L. major infection. Matthew et 
al. (2000) showed that L. major infected IL-13 deficient BALB/c mice (IL-13-/-) developed 
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significantly reduced footpad swellings similar to that of genetically resistant C57BL/6 mice, 
suggesting that IL-13 signalling is also required to inhibit the activation of Type 1 immune 
response which reduces L. major survival [9, 29]. 
On the other hand, IL-4 signalling during Leishmania infection seems to play a dual role in 
polarising the immune response. IL-4 is considered a key cytokine for the establishment of a 
Type 2 immune response, as it is able to downregulate the secretion of IFN-g and IL-12, that 
leads to enhanced susceptibility to L. major infection [25, 30]. However, Bierdermann et al. 
(2001) provided a novel role that suggested that during L. major infection early IL-4 production 
is required initially to drive IL-12 production in dendritic cells, leading to the establishment of 
a Type 1 immune response [27].  
During L. major infection, Vβ4+ Vα8+ CD4+ T cell population have been identified as 
significant contributor’s to early IL-4 production and sustaining IL-4 expression at the site of 
infection [31]. These Vβ4+ Vα8+ CD4+ T cells specifically recognise and respond to the 
Leishmania homolog of receptors for activated C kinase (LACK) antigen from L. major 
parasites, leading to enhanced IL-4 production within 16 hours post infection, during which 
immune polarisation begins [32].  
Notably however, although during L. major infection IL-4 is initially required by dendritic cells 
to establish a Type 1 immune response [27], early production of IL-4 from Vβ4+ Vα8+ CD4+ T 
cells has been simultaneously shown to initiate a Type 2 immune response suggesting cell-
specific differences for IL-4 signalling at the same time point [32]. 
1.5.2 The common IL-4Rα chain during cutaneous leishmaniasis 
The IL-4 receptor alpha (IL-4Rα) chain is a 140kDA complex that has been found to be 
ubiquitously expressed on an array of immune cells including keratinocytes, macrophages, 
dendritic cells, B cells and T cells [6, 26]. The IL-4Rα chain serves as an integral monomer in 
both IL-4 and IL-13 receptors [33, 34]. The IL-4Rα chain integrates with the gamma common 
chain forming the Type 1 IL-4Rα or it integrates with the IL-13 binding receptor 1 (IL-13Rα1) 
forming the Type 2 IL-4α/IL-13Rα1 which binds to IL-13 with higher affinity [34, 35]. The 
IL-4Rα chain, in combination with signal activation of JAK/STAT6 pathway, have been shown 
to be crucial for IL-4 and IL-13 mediated functions [36]. Experiments using anti-IL-4Rα 
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antibodies, were found to inhibit IL-4 and IL-13 signalling via IL-4Rα chain, thereby inhibiting 
their ability to mediate a Type 2 immune response [37, 38]. 
Given that both IL-4 and IL-13 signal via the IL-4Rα and that these cytokines modulate a Type 
2 immune response, that leads to parasite persistence during L. major infection, initial studies 
used global IL-4Rα deficient (IL-4Rα-/-) BALB/c mice, to dissect the mechanism by which IL-
4/IL-13 signalling directs the immune response [25, 39]. Despite the hypothesis that a Type 1 
protective immune response would be elicited, IL-4Rα-/- BALB/c mice were only able to 
control acute L. major infection for 80 days post infection. Following 80 days post infection, 
these IL-4Rα-/- BALB/c mice developed increasing footpad lesions indicating that L. major 
parasites were able to dampen the host’s immune system allowing for sustained parasite 
replication [25]. In contrast, IL-4-deficient and IL-13-deficient BALB/c mice displayed 
sustained resistant phenotypes, implicating that IL-4 and IL-13 as key cytokines in modulating 
susceptibility to L. major [25, 29]. Collectively, these studies indicated that susceptibility to L. 
major may be modulated by a combination of IL-4/IL-13 directed mechanisms and 
mechanisms acting independently of either cytokine. 
The emergence of a sustained Type 2 immune response even in the absence of the IL-4Rα 
chain on all hematopoietic cells [25], led to the development of cell-specific IL-4Rα mice 
models to explore whether IL-4Rα signalling on different innate immune cells or adaptive 
immune cells has an effect on modulating immunity.  
1.6 Cell-specific IL-4Rα deletion mouse models in cutaneous leishmaniasis 
The utilisation of the cre/loxP genetic recombination system, originally identified within 
bacteriophages, has allowed for the generation of murine models in which to assess the IL-4R 
α chain at a cellular level [40]. During embryonic development cyclization recombinase (Cre) 
expression is directed by cell-specific promotors flanked by loxP sites, to selectively delete the 
IL-4Rα chain on specific cell populations under control of a cell-specific promoter [26]. The 
cre/loxP system has provided an efficient targeting strategy to establish the role of IL-4Rα 
signalling within particular cell populations. 
As early produces of IL-4 and abundant innate-like cells contained in the skin, which serves as 
the primary site of infection during cutaneous leishmaniasis, keratinocytes provided a 
favourable cell population for further investigation [41]. A keratinocyte-specific deletion of 
IL-4Rα in KRT14creIL-4Rα−/lox BALB/c and C57BL/6 mice generated, to characterize whether 
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IL-4Rα signalling on this innate-like cell population contributes to susceptibility during L. 
major infection [42]. In L. major infected KRT14creIL-4Rα−/lox C57BL/6 mice and their 
littermate control mice developed similar lesion sizes accompanied by similar parasite burdens 
[43]. Similarly, KRT14creIL-4Rα−/lox BALB/c mice and their littermate control mice developed 
similar increased lesion sizes during L. major infection [42, 43]; this indicated that IL-4Rα 
signalling on keratinocytes does not contribute to the initiation of a Type 2 immune response 
in BALB/c or Type 1 immune response in C57BL/6 mice during L. major infection. 
Following Leishmania inoculation innate macrophages, neutrophils and dendritic cells flux to 
the site of infection, are capable of phagocytosing invading parasites, and play key roles in 
determining Type 1 or Type 2 immune polarization [44]. The sustained Type 2 immune 
response observed in global IL-4Rα deficient mice, led to the proposition that IL-4Rα 
signalling on T cells did not solely drive Th2 cell polarization or lead to enhanced susceptibility 
to L. major infection [39, 45]. Subsequently, Holscher et al. (2006) proposed that the non-
healing susceptible phenotype observed in BALB/c mice was driven by altering the 
polarization of macrophages, as they primarily regulate intracellular Leishmania parasite 
killing [45]. Previous studies have shown that neutrophils are also able to regulate intracellular 
Leishmania killing by forming neutrophil extracellular traps or by activating M1 macrophages 
killer effector functions through TLR4 recruitment [44, 46]. In order to assess if IL-4Rα 
signalling on macrophages and neutrophils played any role in modulating Type 1 or Type 2 
immune response, BALB/c mice were genetically engineered in which the IL-4Rα chain was 
selectively deleted on macrophage and neutrophil populations (LysMcreIL-4Rα-/lox) [47]. The 
absence of IL-4Rα signalling on macrophages and neutrophils led to delayed establishment of 
L. major infection in BALB/c mice up to 13 weeks post infection, which was attributed to 
inhibition of M2 macrophage activation and enhanced NO production by M1 macrophages 
[45]. Collectively, this data suggested that IL-4Rα signalling modulates M2 macrophage 
activation allowing for initial Leishmania replication in BALB/c mice. 
The functional ability of dendritic cells to serve as innate cells that are able to initiate adaptive 
immunity through antigen-presentation [48], provided them as a favourable cell population for 
further analysis. To characterize the functional role of IL-4Rα signalling on dendritic cells 
during L. major infection,  dendritic-cell specific deletion of the IL-4Rα chain was generated 
in a murine model (CD11ccreIL-4Rα-/lox BALB/c mice) [6]. A more susceptible phenotype was 
observed in CD11ccreIL-4Rα-/lox mice, in comparison to the littermate control mice, that was 
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made evident by necrotic lesion development, up-regulation of a Type 2 immune response and  
L. major parasite dissemination into the brain [6]. The impairment of dendritic cells to activate 
NO killing effector mechanisms prevented the elimination of intracellular parasites in these 
infected mice [6]. This data gave new insight that indicated that signalling through the IL-4Rα 
chain is required for the activation of killing-effector mechanisms employed by dendritic cells 
[49], thus suggesting that IL-4Rα signalling on dendritic cells provides a protective role during 
L. major infection. 
As part of the acquired immune cells, B lymphocytes were initially thought to only contribute 
towards host protection or susceptibility to L. major infection through immunoglobulin 
production [50, 51]. Subsequent studies have revealed that stimulated B cells, like T cells, can 
be defined as B effector 1 (Be1) cells and B effector 2 (Be2) cells that are able to produce a 
range of polarizing cytokines including  IFN-g, IL-12 and IL-4 and IL-13 respectively [52, 53]. 
Signals from Th2 cells and the IL-4/IL-4Rα signalling pathway have been reported to be critical 
for differentiation of IL-4 secreting Be2 cells, which in turn are able to maintain CD4+ Th2-
dependent immune responses [53], however the specific role of IL-4Rα signalling on cytokine-
producing B cells during L. major infection remained unknown. 
 To dissect the role of IL-4Rα-responsive B cells during cutaneous leishmaniasis, a BALB/c 
murine model was utilized in which the IL-4Rα chain was selectively deleted on B cells 
(mb1creIL-4Rα–/lox mice) [54]. During L. major infection, mb1creIL-4Rα–/lox BALB/c mice 
showed enhanced control of the disease as they had reduced footpad swellings and a significant 
reduction in parasite burden in the footpad [55]. This improved resistant phenotype observed 
in the absence of IL-4Rα B cells was due to a reduced Type 2 immune response, indicated by 
significantly lower IL-4, IL-13 and IgE levels and consequently a shift towards a Type 1 
immune response was observed to control parasite replication [55]. Collectively, this data 
indicated that IL-4Rα signalling on B cells has a detrimental function during L. major infection, 
as it contributes to enhancing a susceptible Type 2 immune response.                                      
Murine models of L. major infection have delineated that the resistant phenotype observed in 
C57BL/6 mice is promoted by Th1 cells and the susceptible phenotype in BALB/c mice is 
counter-regulated by  Th2 cells [19, 56]. Given that IL-4 signalling solely had been shown to 
have a crucial role in Th2 cell development [57, 58], a CD4+ T cell specific deletion of the IL-
4Rα chain was genetically engineered in BALB/c mice (LckcreIL-4Rα-/lox  BALB/c) to elucidate 
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the role of IL-4Rα signalling on CD4+ T cells [59]. LckcreIL-4Rα-/lox BALB/c mice had 
significantly reduced footpad swellings, reduced parasite burdens in the footpad and draining 
lymph nodes,  accompanied with elevated IFN-g and IL-12 levels similar to resistant C57BL/6 
mice [59]. Subsequent studies showed that iLckcre IL-4Rα−/lox BALB/c mice, in which there 
was pan T cell-specific IL-4Rα deletion, where also able to control L. major infection similar 
to LckcreIL-4Rα-/lox BALB/c and C57BL/6 mice [60]. These data indicated that signalling via 
IL-4Rα on T cell populations (CD4+, CD8+, gd+ and natural killer T cells) has a detrimental 
role as it contributes to the susceptible phenotype observed in BALB/c mice; however since 
this pan T-cell specific IL-4Rα deletion model the specific contribution of T regulatory cells 
remained unclear. 
Collectively, these IL-4Rα-deficient murine models have indicated that IL-4Rα signalling can 
modulate disease outcome during cutaneous leishmaniasis due to its differential role in immune 
cell populations (Table 1.2). This differential role of IL-4Rα signalling has prompted further 
investigation regarding the modes of action of IL-4/IL-13 signalling on an additional T cell 















Table 1.2: The role of IL-4Rα signalling on various immune cell populations during L. major 
infection 
 
1.7.1 The role of regulatory T cells in immunity  
Regulatory T (Treg) cells are a unique subset of CD4+ T cells whose immunosuppressive 
activities are crucial for maintaining immune homeostasis and tolerance to self-antigens [61]. 
Similar to other T cells, Treg cells are derived from progenitor cells in the bone marrow and 
require intermediate signalling via the TCR for successful development [62, 63]. Human Treg 
and mouse Treg cells were initially distinguished from other T cell populations by cluster of 
differentiation 4 (CD4) and CD25 [64, 65]. However, as other T cell population also co-express 
these markers, subsequent studies revealed that forkhead box P3 (Foxp3) expression can be 
used as a specialized marker to discriminate Treg cells from effector and memory T cells which 
are also CD4+ CD25+, as Foxp3 acts as a master transcription factor that drives the development 
and function of Treg cells [66-68]. Foxp3 belongs to the forkhead/winged helix transcription 
factor family and is located on the X-chromosome [69]. The Foxp3 protein is 48kDA and 
Cell Type – IL-4Rα 
Deficient Mouse Strain 
Role of IL-4Rα 
signalling (Protective 
or Detrimental) 
Disease phenotype during IL-4Rα 
deficiency  
All Cells 
(IL-4Rα -/-)   
Both Resistant during acute phase of L. major 
infection; becomes susceptible eleven 
weeks post infection [25] 
Keratinocytes 
(KRT14creIL-4Rα−/lox)  
Neither Susceptible phenotype observed similar 





Detrimental Resistant phenotype driven by inhibition 
of M2 macrophage activation and 
increased NO production [45] 
Dendritic Cells  
( CD11ccreIL-4Rα-/lox)  
Protective Hypersusceptible phenotype due to 
inhibition of dendritic cell mediated 
killer-effector mechanisms [6] 
B Cells 
(mb1creIL-4Rα–/lox) 
Detrimental Resistant phenotype driven by reduction 
in Type 2 immune response [55] 
CD4+ T cells 
(LckcreIL-4Rα-/lox) 
Detrimental Resistant  phenotype  driven by increased 
Th1 cytokine secretion [59] 
Non CD4+ T cells 
(iLckcre IL-4Rα−/lox) 
Detrimental Increased resistant driven by activation 
of Type 1 immune response [60] 
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consists of 4 distinct domains: forkhead domain, leucine zipper, zinc-finger and repressor 
domains, which are required for Foxp3 transcriptional repressive activity [70, 71]. The 
importance of Foxp3+ Treg cells as modulators of the immune system has been established in 
Scurfy mice and human patients with immunodysregulation, poly-endocrinopathy and 
enteropathy, X-linked syndrome (IPEX), as mutations in Foxp3 genes lead to a loss in 
functional Treg cells resulting in the development of fatal autoimmune disease that causes 
lethality in 4-5 week old mice [72, 73].  
 
Several mechanisms are employed by Foxp3+ T reg cells to achieve an immunosuppressive 
effect which include the production of suppressive cytokines- IL-10, IL-35 and transforming 
growth factor beta (TGF-b) [65]. Treg cell-derived IL-10 and TGF-b have been identified 
having crucial roles in mediating the host immune response during Mycobacterium 
tuberculosis (Mtb) infection, suppressing colitis in an Inflammatory Bowel Disease (IBD) 
mouse model and inhibiting airway allergic responses in sensitized mice [74-77]. Gondek et 
al. (2005) provided an additional suppressive mechanism by which Treg cell secretion of 
granzyme B induced cytolysis of effector T cells [78].  Subsequent studies have shown that 
Treg cell expression of granzyme B induces apoptosis of B cells, Natural killer (NK) cells and 
CD8+ cytotoxic T cells [79, 80]. Treg cells, through their expression of inhibitory receptors 
such as co-stimulatory molecule cytotoxic T-lymphocyte antigen (CTLA-4), or programmed 
death-1 (PD-1) are additionally able to induce immunosuppression by modulating the function 
of dendritic cells [81]. CTLA-4 or PD-1 interaction with CD80/86 or programmed death ligand 
1 (PD-L1)  on dendritic cells, induces dendritic cells to produce immunosuppressive molecules 
such as Indoleamine 2,3 dioxygenase (IDO), thereby suppressing effector T cell activation 
[82]. IDO as an immunosuppressive enzyme promotes Treg cell differentiation and diminishes 
the levels of tryptophan, which has been reported to skew T helper polarization [83].  
 
1.8  The role of regulatory T cells during cutaneous leishmaniasis 
Although the suppressive functions of Treg cells had been well characterised, the role of Treg 
cells during cutaneous leishmaniasis remains unclear, as some studies have proposed a 
protective role, whilst others have suggested a detrimental role for Treg cells during L. major 
infection. Treg cells have been postulated to play a critical role in minimizing the levels of 
tissue damage during cutaneous leishmaniasis, due to their modulatory abilities that allow them 
to maintain homoeostasis between Th1 and Th2 cells [84, 85]. In a murine model of L. major 
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infection Foxp3+ Treg cells were shown to accumulate at the site of infection and a similar 
finding was noted in skin lesions from human patients that were diagnosed with cutaneous 
leishmaniasis [84, 86]. 
 
Aseffa et al. (2002) showed that CD4+CD25+ T reg cells were able to control early IL-4 
production by acting on the IL-4 secreting Vβ4 Vα8 CD4+ T cell population [20]. Depletion of 
the CD4+CD25+ Treg cell population in BALB/c mice resulted in increased levels of IL-4 
expression and rendered these mice more susceptible to L. major infection [20]. This data 
suggested that Treg cells have a protective role during cutaneous leishmaniasis, as they play 
an important role in inhibiting early IL-4 production thereby reducing the adverse effects of a 
Type 2 immune response.  
 
In contrast, Suffia et al. (2005) showed that depletion of aE chain (CD103), which is required 
for the homing of Treg cells to the site of infection, led to increased resistance in BALB/c mice 
during L. major infection [87]. In previously infected C57BL/6 mice, re-challenge with L. 
major parasites led to the aggregation of CD4+CD25+ Treg cells at the initial site of infection, 
where they inhibit effector T cells ability to control parasite replication [88]. Treg cells 
sustained inhibition of effector T cells could therefore lead to Leishmania parasite persistence 
and reactivation of infection [86, 88]. Collectively, these data suggest that Treg cells also play 
a detrimental role during L. major infection and this enables sustained Leishmania replication 
during cutaneous leishmaniasis. 
 
Currently, there is no definitive role of Foxp3+ Treg cells during cutaneous leishmaniasis as 
this T cell population is able to contribute to host protection against and lead to sustained L. 
major replication at the site of infection. While Treg cells are required to suppress a detrimental 
Type 2 response, excessive Treg cell accumulation leads to L. major persistence, which 
suggests that for effective protection against L. major infection a balance is required between 
Treg cells and effector T cells [20, 84, 87].  
 
Research that focuses on Treg cell regulation has identified that IL-4, along with various other 
cytokines, are required to modulate Treg function [89]. Previous studies have found that 
reduced Foxp3 expression on Treg cells, lead to their reverting to Th2-like cells, which secrete 
cytokines such as IL-4 and IL-2 and express transcription factor gata binding protein 3 
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(GATA3); indicating evidence of plasticity between Th2 and Treg cell populations [90-92]. A 
previous study has shown that IL-4 signalling via STAT6 was required to maintain to Foxp3 
expression in CD4+CD25+ Treg cells [36]; indicating that IL-4 has a stimulatory effect on Treg 
cell development. In contrast,  Wei et al. (2007) showed that IL-4 secretion by Th2 cells can 
inhibit TGF-b-mediated Treg cell differentiation from naïve CD4+ T cells [93]; indicating that 
IL-4 also has an inhibitory effect on Treg cell development. Given the apparent contradictory 
effects of IL-4 on Treg cell development,  the effects of signalling via the IL-4Rα chain may 
provide further insight with regards to Treg cell development and modulation in vivo. 
 
Although Treg cells act to inhibit early IL-4 production [20], IL-4 signalling via the IL-4Rα 
complex was required to drive Foxp3 expression, highlighting its importance in influencing 
the immunomodulatory activity of Treg cells [20, 36]. IL-4Rα mediated signalling was also 
shown to act on Th cells to increase their resistant to the suppressive activity of Treg cells; 
which further provides an undiscovered role for IL-4Rα signalling in modulating Foxp3+ Treg 
cell function in different disease settings [36]. 
 
1.9 Project Rationale 
The influence of IL-4Rα signalling on Foxp3+ Treg cells has been limited as it has only been 
reported during the context of helminth infection [89]. Treg cells have been identified as a 
crucial CD4+ T cell population involved in modulating the host’s immune response during 
cutaneous leishmaniasis, however the influence of IL-4Rα signalling on Foxp3+ Treg cells 
during L. major infection remains unknown. To enable further investigation into this signalling 
pathway, a L. major model of infection was established in BALB/c mice that were engineered, 
using the cre/loxP system, to selectively delete the IL-4Rα chain on Treg cells under the control 
of the Foxp3+ locus (Foxp3creIL-4Rα-/lox mice) [89]. This present study attempted to provide a 
potential mechanism of action of IL-4Rα signalling that can be targeted to enhance mammalian 








1.10 Aim and Objectives  
 
 The aim of this study is to dissect the role of IL-4Rα signalling on Treg cells during cutaneous 
leishmaniasis 
 
To achieve this aim, we set forth the following objectives: 
- To confirm efficient Cre-mediated deletion of IL-4Rα on Foxp3+ Treg cells during L. 
major infection  
- To characterize the clinical phenotype observed between male and female Foxp3creIL-
4Rα-/lox mice following L. major  infection 
- To characterize the immune responses at cellular and molecular levels elicited in male 
Foxp3creIL-4Rα-/lox male mice during footpad infection 
- To characterize the immune response at a cellular and molecular elicited during an ear 
infection 
- To provide a proposed mechanism for immune response generated in Foxp3creIL-4Rα-
























2. Material and Methods 
2.1 Generation and genotyping of Foxp3creIL-4Rα-/lox mice 
T regulatory cell-specific IL-4Rα deficient (Foxp3creIL-4Rα-/lox) BALB/c mice were generated 
using the cre/loxP system and characterised as previously described [89]. Briefly, Foxp3cre mice 
were crossed with IL-4Rα-/- BALB/c mice [25] and IL-4Rαlox/lox BALB/c mice [47] to generate 
hemizygous Foxp3creIL-4Rα-/lox BALB/c mice. During cutaneous leishmaniasis experiments, 
the following mice groups were included as controls: IL-4Rα-/lox (hemizygous littermate), 
global IL-4Rα-/-, wild type BALB/c mice and C57BL/6 mice. All mice were housed in specific-
pathogen-free conditions in individually ventilated cages within the Animal Unit Facility of 
Health Science Faculty, University of Cape Town. All experimental mice were age and sex-
matched and used between 8-10 weeks of age. Mice were genotyped using PCR, by Miss 
Munadia Ansarie (Division of Immunology), to confirm il-4rα exons 7-9 were removed (Figure 
1) from the genome of Foxp3creIL-4Rα-/lox mice, as previously described [89], using specific 
primers: Forward 5’-CTG CTT CCT TCA CGA CAT TCA AC-3’ and Reverse 5’-AAG TGC 








Figure 2.1: Schematic diagram representing the structure of the IL-4Rα gene on the Foxp3 
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2.2 Ethics Statement  
This study was performed in strict accordance with recommendations of the South African 
National guidelines.  All mice experiments were performed according to protocols approved 
by the Science Faculty Biological Safety Committee, BSC005_2016 and by the Animal 
Research Ethics Committee at the Faculty of Health Sciences, University of Cape Town 
(Permit numbers: 015/034 and 019/001; South African Veterinary Council Authorisation 
number: AR18/1696). All efforts were made to minimize the suffering of the animals. 
2.3 Preparation of L. major LV39 parasite culture from frozen stocks 
L. major LV39 (MRHO/SV/59/P) parasite stocks were stored in liquid nitrogen. A total of 
2x108 parasite pellet were stored in a 2 ml cryovial (Corning, USA) containing medium 199 
(M199) (Gibco, USA) supplemented with 8% dimethyl sulphoxide (DMSO) (Sigma-Aldrich, 
USA)  and 92% fetal bovine serum (FBS) ( Thermofischer Scientific Pierce, USA). To generate 
a viable parasite culture, a L. major LV39 stock was defrosted at room temperature, 
resuspended in 8 ml 1x phosphate buffered saline (PBS), pH 7.4, and centrifuged at 23°C for 
10 minutes at 3000rpm. The parasite pellet was resuspended in 10 ml 1xPBS and pelleted by 
centrifugation at 23°C for 10 minutes at 3000rpm. The parasite pellet was resuspended in 5 ml 
M199 supplemented with  10 % FBS, 50 units/ml penicillin and 50 µg/ml streptavidin 
(complete M199), transferred to a 25cm3 tissue culture flasks (Corning, USA) and subsequently 
incubated at 26°C. An equivalent volume of complete M199 was added to the 25cm3 tissue 
culture flasks once the parasites reached confluency. 
L. major in vitro cultures were maintained by subculturing as previously described [25]. 
Briefly, parasite cultures were maintained by weekly subculturing 1:50 of L .major LV39 
parasites into new tissue culture flask containing 10 ml complete M199  and incubated at 26°C.  
2.4 L. major infections 
 
2.4.1 Preparation of L. major culture growth curve and preparation for infection in mice 
L. major in vitro cultures were subcultured as described above, however in preparation for 
infection  L. major LV39 promastigotes were transferred from 25cm3 tissue culture flasks to 
50 ml Falcon tube and centrifuged at 4000rpm for 10 minutes at 23°C. The parasite pellet was 
resuspended and washed twice in 1xPBS, and subsequently centrifuged at 3000rpm for 10 
minutes at 23°C. Following resuspension in 3 ml 1xPBS, parasites were fixed in 4% 
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paraformaldehyde and counted using a Neubauer haemocytometer. To initiate a growth curve 
10x106 L. major promastigotes were transferred into 10 ml of M199 media and incubated at 
26°C in a humified incubator. L. major in vitro cultures were counted daily and plotted as an 
exponential curve. 
L. major LV39 parasites were prepared for infection as previously described [25]. Briefly, after 
6 days at 26°C, stationary phase L. major parasites were centrifuged at 500rpm for 10 minutes 
at 23°C, to pellet out cell debris and lipids. The parasite solution was then pelleted by 
centrifugation at 3000rpm for 10 minutes at 23°C and washed twice in 1xPBS. Following 
resuspension in 1x PBS, the parasites were fixed with 4% paraformaldehyde, counted using a 
Neubauer haemocytometer and adjusted for infection studies.  The concentration of L. major 
promastigotes were adjusted to 2x106/50 µl of 1xPBS or 1x104/10 µl 1x PBS for footpad or ear 
infections respectively. Prior to infection, experimental mice were anaesthetized by 
intraperitoneal (i.p) injection consisting of 12% ketamine and 8% xylavet made up in 1x PBS 
at a dose of 10 µl/gram.  
2.4.2 L. major footpad infection in mice 
Anaesthetized mice were subcutaneously injected in the left hind footpad with 2x106 stationary 
phase L. major promastigotes in 50 µl of 1xPBS. Disease progression was monitored weekly, 
by measuring changes in infected footpad swellings using a Mitutoyo micrometer caliper 
(Brütsch-Rüegger, Switzerland). 
To maintain L. major in vitro cultures, at 8 weeks post infection mice were sacrificed by 
halothane inhalation followed by cervical dislocation. 200µl 1x PBS was aspirated within the 
mouse infected footpad. An amastigote parasite solution was extracted, and transferred to 15ml 
Falcon tube containing 2 ml 1x PBS and centrifuged at 3000rpm for 5 minutes at 25°C. The 
parasite pellet was resuspended in 2 ml M199 media and transferred to a 25cm3 tissue culture 
flask containing 8 ml M199 media and incubated in 26°C humified incubator, to allow for 
efficient replication and differentiation into the promastigote form. 
2.4.3 L. major ear infection in mice 
Alternatively, anaesthetized mice were intradermally injected into the left ear with 1x104 
stationary phase L. major promastigotes in 10 µl of 1x PBS [94]. Disease progression was 
monitored weekly, by measuring changes in lesion diameter in an infected ear weekly using a 
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Vernier caliper (Massmart Holdings, South Africa). The mice were monitored daily and the 
weight of all experimental mice were recorded weekly to assess overall welfare until they 
reached the experimental endpoint. Mice infected with L. major LV39 were sacrificed at 8 
weeks post infection. 
2.4.4 Isolation of soluble Leishmania antigen from L. major cultures 
Frozen L. major LV39 samples prepared from in vitro cultures, as described in Section 2.4.3 
were thawed at 4°C and centrifuged at 3000rpm for 10 minutes at 4°C.  The parasite pellet was 
resuspended in PBS-containing protease inhibitor cocktail (1:100)  (Sigma-Aldrich, USA), to 
prevent protein degradation. The pellet sample was subsequently sonicated 4 times for 20 
second cycles (amplitude 3) and the samples were stored at 4°C between sonication cycles. 
The suspensions were centrifuged at 8000rpm for 10 minutes at 4°C to pellet debris and the 
supernatant containing soluble leishmania antigen (SLA) was filtered through a 0.22µm	filter. 
The protein concentration of the SLA samples were determined using a bicinchoninic acid 
protein assay (BCA) (Thermofischer Scientific Pierce, USA) according to the manufacturer’s 
protocol. The SLA samples were aliquoted in 0.5 ml Eppendorf tubes and stored at -80°C. 
2.5 Quantification of  L. major parasite burden  
2.5.1 Limiting Dilution Assay (LDA) to detect viable parasite burden 
 
Following infection of mice with L. major LV39 parasites infected footpads, ears, spleens and 
draining lymph nodes were collected for further analysis. Detection of viable parasite burden 
was assessed by two-fold limiting dilution assay as previously described  [25]. Briefly, 
footpads and spleens were collected in 2 ml complete M199 media and homogenized in 
complete M199 media, whilst popliteal and cervical lymph nodes were collected in 1 ml 
Dulbecco’s modified eagle medium (DMEM) (Gibco, USA) supplemented with 10% FBS, 100 
units/ml penicillin, 100 µg/ml streptomycin, 0.1% b-mercaptoethanol and 1% HEPES buffer 
(Lonza, Belgium). The samples were teased through a 40µm filter (Falcon, USA) to create 
single-cell suspensions in a final volume of 6.4 ml (100 µl= 26 parasites) by adding 5.4 ml 
complete DMEM. Two-fold serial dilutions from each tissue suspension were prepared in 96-
well flat-bottom plates using complete M199 media in a final volume of 100 µl. The plates 
were incubated for 7 days at 26°C; thereafter each well was observed using an Olympus SC30 
and the parasite burden was scored microscopically as being the lowest two-fold dilution (2n) 




2.5.2 DNA extraction from L. major infected footpad  samples 
 
 To extract DNA from the infected samples, 800 µl of footpad homogenate was transferred to  
1.5 ml Eppendorf tubes and centrifuged at 5000rpm for 10 minutes at 4°C.  The pellets, which 
contain murine and amastigote DNA, were then stored at -80°C until DNA extraction. As a 
positive control, stationary phase parasite cultures in 1x PBS were transferred to 1.5 ml 
Eppendorf tubes and centrifuged at 5000rpm for 10 minutes at 4°C. The pellets were stored at 
-20°C until DNA extraction. 
 
Genomic DNA was isolated from the pellets as previously described [95] with modifications. 
The pellets were resuspended in 450 µl Saline/EDTA buffer (40mM NaCl and 10mM EDTA, 
pH 8) and 50 µl of 10% sodium dodecyl sulphate (SDS) was added to solubilise proteins.  
Following this 20 µl of 20 mg/ml proteinase K was added to digest contaminating nucleases 
and the Eppendorf tubes were vortexed briefly. Following this the samples were incubated for 
2 hours at 56°C to lyse the cells. In order to precipitate out proteins, 225 µl of 5M NaCl was 
added and the samples were incubated at room temperature for 1 hour. The samples were 
centrifuged at 10 000rpm for 10 minutes at 4°C. The supernatant was then transferred to fresh 
1.5 ml Eppendorf tubes and recentrifuged at 10 000rpm for 10 minutes at 4°C. The supernatant 
was then transferred to fresh 2 ml Eppendorf tubes, 1ml of ice cold isopropanol was added to 
each sample, and the samples were incubated overnight at -20°C to precipitate genomic DNA. 
After this incubation to pellet the genomic DNA, the samples were centrifuged at 10 000rpm 
for 20 minutes at 4°C. The pellet was then washed in 1 ml of 70% Ethanol and centrifuged 
10000rpm for 20 minutes at 4°C. The pellet was dried at room temperature for 1 hour to allow 
the excessive 70% Ethanol to evaporate. The pellet was resuspended in 30 µl of TE buffer 
(10mM Tris, 1mM EDTA, pH 8). The DNA yield for each sample was measured using a 
nanodrop ND1000 (Thermo Scientific, USA). The quality of DNA was further confirmed by 
loading 5 µl of sample and 1 µl of Tritrack loading dye (Thermofischer scientific, South Africa) 
in a 1.5% agarose gel (1.5 g agarose gel in 100 ml 1x Tris-Borate-EDTA buffer containing 5 
µl of 10 mg/ml ethidium bromide stock). The gel was allowed to run for 20 minutes at a 100V 




2.5.3 Endpoint PCR 
 
To detect Leishmania kinetoplast DNA (kDNA) from DNA samples, as prepared in Section 
2.5.2, endpoint PCR was performed as previously described [96, 97]. The following 
JW11/JW12 primers for Leishmania kDNA were used to amplify a 120bp fragment: Forward 
5’-CCT ATT TTA CAC CAA CCC CCA GT-3’ and Reverse 5’-GGG TAG GGGG CGT TCT 
GCG AAA-3’ (IDT, South Africa). Briefly, 5 ng/µl extracted gDNA was amplified in a mix 
containing 0.2 µM of forward primer, 0.2 µM reverse primer, 1.5 mM MgCl2, 0.2mM each 
deoxynucleotide triphosphate and 0.2 units of Taq DNA polymerase (KAPA Taq PCR 
Readymix KK1024; KAPA Biosystems, USA) in a 10 µl final volume. PCR was performed on 
an XP thermal cycler (Bioer Technology, China) under the following conditions: initial 
denaturation at 94°C for 4 minutes, followed by 30 cycles (denaturation for 1 min at 94°C, 
annealing for 30 seconds at 58°C, elongation for 30 seconds at 72°C) and conditions were 
terminated by a final extension for 10 minutes at 72°C. A volume of 5 µl from each PCR 
product was run at 100 volts for 30 minutes on 1.5% [w/v] agarose gel stained with ethidium 
bromide (5 µg/ml) in 1x Tris-EDTA buffer. The PCR products were visualised using a Syngene 
G box and images were captured using Genesnap software (Syngene Synoptics, UK). PCR 
product images were quantified using ImageJ software (National Institutes of Health, USA). 
The relative expression levels of amastigote kDNA, from equivalent 5 ng/µl DNA isolated 
from infected samples, was determined as the intensity from each band on the visualized gel 
normalized to the intensity from pure L. major parasite in vitro cultures as a positive control. 
2.6 Isolation and stimulation of draining lymph node cells 
Lymph nodes were isolated and prepared as described in Section 2.5.1. Lymph node cells were 
centrifuged at 1300rpm  for 5 minutes at 4°C and the pellet was resuspended in 3 ml complete 
DMEM, re-filtered through a 40µm filter and the number of viable cells was determined by 
trypan blue staining using a 1:50 dilution. Cells were made up to 1x107 cells in complete 
DMEM. The cells were plated at 1x106/ml in 48-well flat-bottom plates (Corning, USA) and 
left unstimulated or stimulated with 20 µg/ml plate-bound α-CD3. The plates were placed in a 
37°C incubator with 5%CO2 for 72 hours. Following incubation, the plates were centrifuged at 
1300rpm  for 5 minutes at 4°C and the supernatants were stored at -20°C until used for 
detection of cytokines. 
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2.7  Flow cytometry analysis of lymph node cells 
2.7.1 Extracellular surface staining 
Lymph node cells were isolated, as described in Section 2.6, seeded at 2x106 cells/well from 
each sample in 96-well v-bottom plates (Nalge Nunc International, USA) and centrifuged at 
1500rpm for 5 minutes at 4°C. Following centrifugation, the supernatants were discarded and 
the pelleted cells were resuspended in 50 µl of antibody surface mix prepared in FACS buffer 
(0.5% BSA in 1xPBS, pH 7.4) supplemented with 1% heat-inactivated rat serum (iRS) and 10 
µg/ml anti-FcgR (2.4G2). The plates were covered in tin foil and incubated for 20 minutes at 
4°C. After incubation, 150 µl of FACS buffer was added to each sample to wash out unbound 
antibodies and the cells were centrifuged at 1200rpm for 5 minutes at 4°C. Following this, the 
supernatant was discarded and the stained cells were resuspended in 200 µl FACS buffer until 
acquisition. 
2.7.2 Intranuclear staining 
In preparation for cytokine staining, 2x10
6 lymph node cells/well were seeded in a 96-well U 
bottom plate (Nalge Nunc International, USA) and stimulated for 2 hours at 37°C  in  10 µl 
complete DMEM containing 50 ng/ml phorbol myristate acetate (PMA) (Sigma-Aldrich, USA) 
and 250 ng/ml ionomycin (Sigma-Aldrich, USA); this stimulation was done to enhance 
intracellular cytokine production [98]. After incubation,  10 µl complete DMEM with 200 µM 
monensin was added to each sample and the cells were furthered incubated for 4 hours at 37°C; 
this treatment was performed to block cytokine secretion out of the Golgi apparatus [99]. 
Following incubation, the re-stimulated cells were transferred to a new V-bottom plate and 
centrifuged at 1500rpm for 5 minutes at 4°C. The supernatant was discarded gently. T and B 
cells populations were identified by staining with extracellular antibodies for CD3, CD4, CD8, 
CD19, PD-1, IL-4Rα (Appendix 1), as described in Section 2.7.1. For intranuclear staining, 
Anti-mouse/Rat Foxp3 staining set (77-5775) (eBioscience, Thermofischer South Africa) was 
used as per the manufacturer’s protocol with modifications; this allowed for detection of 
intracellular molecules and intranuclear transcription factors. Briefly following extracellular 
staining, cells were washed with 150 µl Foxp3 Permeabilization buffer (diluted 1:10 in distilled 
H2O) and centrifuged at 1500rpm for 5 minutes at 4°C.  The pelleted cells were fixed and 
permeabilized in 100 µl Fixation-Permeabilization working solution (1 part 
Fixation/Permeabilization concentrate: 3 parts Fixation/Permeabilization diluent) covered in 
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tin foil for 30 minutes at 4°C. Cells were centrifuged at 1500rpm for 5 minutes at 4°C and 
washed twice in 150 µl Foxp3 Permeabilization buffer. Cells were stained with 50 µl of 
antibody mixes, prepared in Foxp3 Permeabilization buffer supplemented with 2% iRS and 10 
µg/ml anti-FcyR, against intracellular IFN-γ, IL-4, IL-13, IL-10, and intranuclear transcription 
factors:  GATA3, T-bet, RoRγt and Foxp3 (Appendix 1). The plates were covered in tin foil 
and cells were stained for 50 minutes at 4°C. The cells were washed in 150 µl Foxp3 
Permeabilization buffer, centrifuged at 1500rpm for 5 minutes at 4°C and subsequently 
resuspended in 200 µl FACS buffer at 4°C until acquisition. 
 
2.7.3 Intracellular staining 
For intracellular staining, lymph node cells were isolated, seeded at 2x106 cells/well and 
dendritic cell populations were identified by staining with surface marker antibodies for 
CD11c, CD11b, MHC-II, B220, PD-L1 and CD80 (Appendix 1), as described in Section 2.7.1. 
Following staining, cells were washed with 150 µl FACS buffer and centrifuged at 1500rpm 
for 5 minutes at 4°C. The cell pellets were then fixed in 200 µl 2% paraformaldehyde for 20 
minutes at 4°C. The cells were washed with 200 µl 1xPBS and centrifuged at 1500rpm for 5 
minutes at 4°C. The cell pellets were subsequently permeabilized with 200 µl Permeabilization 
buffer (0.11% CaCl2, 0.1% saponin, 0.1% BSA, 0.05% NaN3, 0.0125% MgSO4, 10mM Hepes 
in 1xPBS, pH 7.4) for 30 minutes at 4°C. The cells were centrifuged at 1500rpm for 5 minutes 
at  4°C, followed by intracellular staining with 50 µl per well of anti-mouse IDO (Appendix 
1), prepared in Permeabilization buffer supplemented with 2% iRS and 10 µg/ml anti-FcyR, 
for 50 minutes at 4°C. Biotin-labelled antibodies were detected by staining with 50 µl of 
Streptavidin conjugated to PE-CF594 (Appendix 1). Cells were then washed with 150 µl 
Permeabilization buffer, centrifuged at 1500rpm for 5 minutes at 4°C and resuspended in 200 
µl FACS buffer at 4°C until acquisition. 
Cell acquisition was completed on BD LSRFortessa Machine (BD Biosciences, USA) and data 









2.8 Serum collection from blood samples 
 
Following sacrifice, blood samples were collected from each mouse by cardiac puncture using 
an insulin syringe and transferred to serum separator tubes (BD Bioscience, USA). The samples 
were centrifuged at 8000rpm at 4°C for 10 minutes and stored at -80°C until further analysis. 
 
2.9 Nitric Oxide Synthase and Arginase activity 
 
Lymph node cells collected and seeded at 2x106 cells/ml, as described in section 1.4.3, were 
stimulated with 10 ng/ml LPS in 37°C incubator with 5%CO2 for 72 hours. Following 
incubation, the plates were centrifuged at 1300rpm  for 5 minutes at 4°C and the supernatants 
were collected for quantification of nitrite production as an indication of iNOS activity as 
previously described [100]. Briefly, a Griess reagent standard (1 mM NaNO2) was serially 
diluted 2-fold in DMEM in a 96-well flat-bottom plate and 50 µl of supernatants were added. 
Following this 25 μl Griess Reagent 1 (1 % sulphanilamide in 2.5% phosphoric acid) was added 
per well and the plate was incubated for 5 minutes in the dark. An equal volume Griess Reagent 
2 (0.1% naphthyl-ethylenediamine in 2.5% phosphoric acid) was added per well and the plate 
was incubated for 10 minutes in the dark until a pink colour develops across the standard wells. 
The optical density was measured at 540nm on a VersaMaxTM microplate reader using Softmax 
pro software (Molecular Devices, Germany). 
 
Arginase activity within infected cell lysates was determined as previously described. Briefly, 
100 μl 0.1% Triton X-100 per well was used to lyse infected cells. After lysis, 50 μl of lysed 
cells were transferred to a new 96-well flat-bottom plate and 50 μl Arginase buffer (50 mM 
Tris-HCl and 10 mM MnCl2 pH 7.5) was added per well. Arginase activity was then activated 
by heating for 10 minutes at 55°C. Following incubation, 25 μl of activated lysate and 25μl  of 
0.5 M arginine pH 9.7 were added in combination and the plate was incubated at 37°C for 1 
hour to induce arginine hydrolysis. As a measure of arginase activity, Urea (5 mg/ml) was 
added and diluted as 2-fold dilution series in distilled H2O to generate a standard curve. The 
reaction was stopped by adding 200 μl of H2SO4: H3PO4: H2O (1:3:7). Following this 12.5 μl 
of 9% isonitrosopropiophenone (dissolved in 100% Ethanol) was added and the plates were 
heated at 100°C for 45 minutes.  The optical density was measured at 540nm on a VersaMaxTM 





2.10 Enzyme-linked Immunosorbent Assay (ELISA) Analysis 
 
2.10.1 Cytokine ELISA 
 
Cytokine secretion in L. major infected lymph node supernatants (as prepared in Section 2.6) 
was detected by sandwich ELISA as previously described [25]. Briefly, 96-well flat bottom 
plates (Nalge Nunc International, USA) were coated with primary coating antibodies specific 
for each cytokine of interest (Appendix 2), diluted in carbonate coating buffer (1.5 mM 
Na2CO3, 35 mM NaHCO3 and 71 mM NaCl, pH 9.5) and incubated at 4°C overnight. The 
plates were then washed 4 times in washing buffer and blocked with 2% BSA for 2 hours at 
37°C. The plates were then washed 4 times in washing buffer and recombinant cytokine 
standards (Appendix 2) or  lymph node supernatants were added in 3-fold serial dilutions and  
incubated at 4°C overnight. Following overnight incubation, the plates were washed 4 times in 
washing buffer. Biotinylated secondary anti-mouse antibodies for each cytokine were then 
added and the plates were incubated at 4°C overnight.  The plates were then washed 5 times in 
washing buffer and streptavidin substrate conjugated with alkaline phosphatase (AP) (1:1000) 
or horse-radish peroxidase (HRP) (1:5000) was added and incubated for 1 hour at 37°C.   
 
The plates treated with HRP-conjugated streptavidin were incubated with  TMB peroxidase 
substrate (KPL, USA) and the reaction was stopped with 1M H2PO4. The optical density was 
recorded at 450nm-540nm  on a VersaMaxTM microplate reader.  The plates treated with AP-
labelled streptavidin were developed  by adding 4-Nitrophenyl phosphate (1 mg/ml PNP in AP 
substrate buffer: 9.7% C4H11NO2, 0.02% NaN3 and 0.8% MgCl2.6H2O, pH 9.8) and incubated 
for 15 minutes at room temperature. Absorbance was recorded on a VersaMaxTM microplate 
reader at 405-492nm.  
 
2.10.2 Antibody ELISA 
 
Antibody response was measured in mouse serum samples collected as described in Section 
1.4.4. Antigen-specific IgG1 and IgG2b were measured by indirect ELISA and total IgE was 
measured by sandwich ELISA as previously described [25]. Briefly, 96 well plates (Nalge 
Nunc International, USA) were coated with 5 µg/ml L. major SLA or 1 µg/ml IgE clone 84.1C 
(Southern Biotechnology, USA) in PBS coating buffer (pH 9.5) and incubated at 4°C 
overnight. Following overnight incubation, the wells were washed 4 times in 1x washing buffer 
and blocked with 2% BSA for 2 hours at 37°C. The plates were washed 4 times and serum 
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(diluted 1:10 in dilution buffer) was added in a 3-fold dilution series. For Total IgE ELISA 
plates, 100 ng/ml IgE standard (BD Pharmingen, USA) was added in a 3-fold serial dilution. 
The plates were then incubated overnight at 4°C. After washing 4 times, alkaline phosphatase-
conjugated goat anti-mouse IgG1, IgG2b and IgE secondary antibodies (Southern 
Biotechnology, USA) were added and the plates were incubated at 4°C overnight. The plates 
were developed following incubation with PNP substrate as described in Section 1.5.1 and the 
absorbance was recorded at 405-492nm on a VersaMaxTM microplate reader. 
 
2.11 Statistical Analysis 
Statistical analyses were performed using Graphpad Prism v6.2 (GraphPad Software, USA). 
The data were calculated as mean ± Standard error of the  mean (SEM). Statistical analysis was 
calculated using unpaired student t-test (two-tailed with unequal variance) between 2 groups 
or one-way Analysis of Variance (ANOVA) with a Bonferroni multiple comparison post-hoc 
test was used to compare more than 2 groups. Differences to  IL-4Rα-/lox mice were defined as 



























3.1 Preparation of L. major LV39 parasites for infection  
 
In preparation for infection in experimental mice, L. major LV39 promastigotes were cultured 
at a fixed parasite number and promastigote numbers were counted daily, following fixation in 
4% paraformaldehyde (Figure 3.1). During days 2 to 4 post culturing, logarithmic growth was 
initially observed; following this on day 6 the L. major promastigote numbers plateaued as they 
reached stationary phase (Figure 3.1). Subsequently these stationary-phase L. major 

















3.2 Differential Cre-mediated deletion of IL-4Rα on Foxp3+ Treg cells between 
Foxp3creIL-4Rα-/lox male and female mice is maintained during L. major infection 
Previous studies have reported that IL-4Rα chain is a complex, expressed on an array of cell 
types including hematopoietic, endothelial, epithelial, hepatocyte and brain tissue [34, 102]. 
Following L. major LV39 infection, surface expression of the IL-4Rα chain on various immune 
cell populations was initially assessed at a protein level by flow cytometry analysis (Figure 3.2 
and Figure 3.3). The CD19+ B cell and CD4+ T cell populations were gated as shown in 
Supplementary Figure 1. The total IL-4Rα expression at an individual cell level was defined 
as the geometric mean fluorescent intensity (GMFI). In line with trends found in a previous 
study, CD19+ B cell and CD4+ Foxp3- T cell populations from Foxp3creIL-4Rα-/lox mice and 
their littermate controls had comparable IL-Rα GFMI expression (Figure 3.2 and Figure 3.3) 
[89]. The significant reduction in IL-4Rα GMFI on CD4+ Foxp3+ Treg cells observed in IL-






















Figure 3.1: Growth curve of L. major LV39 promastigotes in preparation for infection. 1x10
6 parasites/ml 
of complete M199 medium were subcultured into 25cm3 tissue culture flasks and parasite numbers were counted 
daily to determine the stationary growth phase (depicted by arrow). Consequently, on day 6 L. major LV39 
(MRHO/SV/59/P)  promastigotes were used for infection. Results are the mean parasite  counts ± SEM from 5 
pooled LV39 cultured flasks.  
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4Rα-/- mice, which are deficient of the IL-4Rα chain on all hematopoietic cells [39],  
corresponded to a similar reduction observed in Foxp3creIL-4Rα-/lox male and female mice 
(Figure 3.2 and Figure 3.3), indicating successful depletion of the IL-4Rα chain within CD4+ 










Figure 3.2: Efficient deletion of the IL-4Rα chain on T regulatory cells is maintained within 
Foxp3creIL-4Rα-/lox male mice during L. major infection. Experimental male mice were 
subcutaneously infected with 2x106 stationary phase L. major LV39 promastigotes into the left hind 
footpad. At 8 weeks post infection, geometric mean fluorescent intensity (GMFI) of IL-4Rα 
expression was determined by flow cytometry analysis from the popliteal lymph nodes of L. major 
infected IL-4Rα-/lox, Foxp3creIL-4Rα-/lox and IL-4Rα-/-  male mice. B cells were CD19+CD3-,  non-Treg 
T cells were CD4+Foxp3- and Treg cells were CD4+Foxp3+. Results are representative of two 
independent experiments with 5 mice per group expressed as mean±SEM. Statistical significance was 














Figure 3.3: Deletion of the IL-4Rα chain is specific to T regulatory cells in L. major infected 
Foxp3creIL-4Rα-/lox female mice. Experimental male mice were subcutaneously infected with 2x106 
stationary phase L. major LV39 promastigotes into the left hind footpad. At 8 weeks post infection, 
geometric mean fluorescent intensity (GMFI) of IL-4Rα expression from the popliteal lymph nodes of 
L. major infected IL-4Rα-/lox, Foxp3creIL-4Rα-/lox and IL-4Rα-/-  female mice. B cells were CD19+CD3-,  
non-Treg T cells were CD4+Foxp3- and Treg cells were CD4+Foxp3+. Results are representative of two 
independent experiments with 5 mice per group expressed as mean±SEM. Statistical significance was 









































































































































































 A previous study had reported that at naïve level, in the spleen and mesenteric lymph node 
(MLN), a difference in deletion efficiency of IL-4Rα chain on CD4+ Foxp3+ Treg cells was 
noted between Foxp3creIL-4Rα-/lox male mice and female mice [89]. To assess whether the 
deletion efficiencies were maintained during L. major infection, popliteal lymph nodes were 
isolated from L. major infected male and female mice following 8 weeks of infection and the 
deletion efficiency was quantified using a previously derived formula [89]. The deletion 
efficiency of the IL-4Rα chain in CD4+ Foxp3+ Treg cells was significantly reduced in 
Foxp3creIL-4Rα-/lox female mice (Average Efficiency of deletion(Ed) = 32,48%) compared to 
Foxp3creIL-4Rα-/lox male mice (Ed=102,73%). Collectively, these data suggest that the Cre-
mediated deletion of IL-4Rα signalling is specific to the CD4+ Foxp3+ Treg cell population and 
that the differential deletion efficiency observed between  Foxp3creIL-4Rα-/lox male and female 















Figure 3.4: Differential Cre-mediated deletion of the IL-4Rα chain on Foxp3+ Treg cells between 
female and male Foxp3creIL-4Rα-/lox mice is conserved during L. major infection. Experimental 
mice were subcutaneously infected with 2x106 stationary phase L. major LV39 promastigotes into the 
left hind footpad. At 8 weeks post infection, the deletion efficiency of the IL-4Rα chain on 
CD4+Foxp3+ Treg cells was calculated in the popliteal lymph nodes of L. major infected female and 
male Foxp3creIL-4Rα-/lox mice. Results are representative of two independent experiments with 5 mice 
per group expressed as mean±SEM. Statistical significance was determined in comparison to 




























































































3.3 Foxp3IL-4Rα-/lox BALB/c male mice are hypersusceptible to L. major during footpad 
infection 
3.3.1 Characterization of the clinical phenotype observed during L. major LV39 infection 
In order to investigate the role of IL-4Rα signalling on Foxp3+ Treg cells during cutaneous 
leishmaniasis, experimental mice were infected subcutaneously in the left hind footpad with 
2x106 stationary phase L. major promastigotes. Footpad swellings were measured weekly over 
as an indication of disease progression (Figure 3.5, A-B). Similar to previous studies, 
susceptible IL-4Rα-/lox littermate control female and male mice developed enhanced footpad 
swellings during the course of L. major LV39 infection (Figure 3.5, A-B) [47, 59]. Notably, 
Foxp3creIL-4Rα-/lox BALB/c female mice developed enhanced footpad swellings, similar to 
their littermate control (IL-4Rα-/lox) (Figure 3.5A), which correlated with similar parasite 
burdens in infected footpads (Figure 3.6A), draining popliteal lymph nodes (Figure 3.6B) and 
spleens (Figure 3.6C). The PCR products of Leishmania amastigote kDNA isolated from 
infected footpad samples were electrophoresed on a 1.5% agarose gel and visualized by UV 
illumination using a Syngene G box (Supplementary Figure 2). Similar to the results observed 
during LDA parasite burdens, no significant difference was identified in the relative amastigote 
kDNA expression levels between Foxp3creIL-4Rα-/lox female footpad samples and their 
littermate controls (Figure 3.7A).  
In contrast, Foxp3creIL-4Rα-/lox BALB/c male mice developed significantly larger footpad 
swellings and early necrosis was noted for a greater number of mice, in comparison to their 
littermate controls during L. major infection (Figure 3.5B). This increased disease progression 
observed in L. major infected Foxp3creIL-4Rα-/lox BALB/c male mice was associated with 
significantly greater parasite burdens in infected footpads (Figure 3.6D), lymph nodes (Figure 
3.6E) and enhanced parasite dissemination to the spleen (Figure 3.6F). The significantly 
enhanced relative amastigote kDNA expression levels of Foxp3creIL-4Rα-/lox male footpad 
samples (Figure 3.7B), provided further evidence of increased parasite loads at the site of 
infection. In line with previous studies [25, 59], resistant C57BL/6 female and male mice were 
able to resolve lesion development during the 8 week L. major LV39 infection period (Figure 
3.5, A-B); accompanied with significantly lower parasite burdens in the infected footpads, 
lymph nodes and spleens (Figure 3.6, A-F). Collectively, these results suggest that the greater 
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efficiency of deletion of the IL-4Rα chain on Treg cells,  the more susceptible Foxp3creIL-4Rα-
/lox mice strain appeared to be to L. major infection; thus suggesting that IL-4Rα signalling on 















Figure 3.5: The absence of IL-4Rα signalling on T regulatory cells renders Foxp3IL-4Rα-/lox male 
mice hypersusceptible to L. major infection; while Foxp3IL-4Rα-/lox female mice remain as 
susceptible as their littermate control. Experimental mice were subcutaneously infected with 2x106 
stationary phase L. major LV39 promastigotes into the left hind footpad. Changes in diameter at the 
site of infection was measured weekly as footpad swelling (mm). Footpad swelling for female (A) and 
male mice (B) was measured over an 8 week period. Necrosis is indicated by “N” per number of mice 
in which it was observed. Results are representative of two independent experiments with 5 mice per 
group expressed as mean±SEM. Statistical significance was determined in comparison to IL-4Rα-/lox 
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Figure 3.6: The L. major parasite burdens are significantly increased in Foxp3creIL-4Rα-/lox male 
mice. Experimental mice were subcutaneously infected with 2x106 stationary phase L. major LV39 
promastigotes into the left hind footpad. The parasite burden (2n) within female mice footpads (A), 
lymph nodes (B) and spleens (C) at week 8 post infection with L. major was determined by limiting 
dilution assays. Similarly, limiting dilution assays were used to determine parasite burden within male 
mice footpads (D), lymph nodes (E) and spleens (F). The limit of detection (26) is indicated as a dashed 
line. Results are representative of two independent experiments with 5 mice per group expressed as 
mean±SEM. Statistical significance was determined in comparison to IL-4Rα-/lox mice (*, p≤0.05; **, 











Figure 3.7: The L. major parasite loads are significantly increased in Foxp3creIL-4Rα-/lox male 
mice. Experimental mice were subcutaneously infected with 2x106 stationary phase L.major LV39 
promastigotes into the left hind footpad. At 8 weeks post L. major infection the relative amastigote 
kinetoplast DNA from DNA samples extracted from female (A) and (B) male homogenized footpads, 
were quantified by densitometry using ImageJ software. The relative expression levels were normalized 
to L. major in vitro cultures. Results are representative of one independent experiment with 5 mice per 
group expressed as mean±SEM. Statistical significance was determined in comparison to IL-4Rα-/lox 
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3.3.2 Immunological responses observed at the cellular level 
 
As Foxp3creIL-4Rα-/lox  male mice showed greater L. major parasite dissemination, indicative 
of enhanced susceptibility during L. major LV39 infection, we sought to assess the recruitment 
of cells in the isolated draining lymph nodes. At 8 weeks post infection, the total number of 
lymph node cells were comparable between the three mice strains (Figure 3.8). (Foxp3creIL-
4Rα-/lox, IL-4Rα-/lox littermate control and C57BL/6 resistant control mice).  
 
Previous studies have elucidated that mechanisms employed by Treg cells to modulate the host 
immune response involve cytokine production [61, 74]. Given this, we sought to determine the 
effect on Treg cell population cytokine levels following the deletion of IL-4Rα signalling on 
Foxp3+ Treg cells. The intracellular cytokine staining and gating of Foxp3+ Treg cell 
population by flow cytometry (Supplementary Figure 3), allowed for the frequency of Foxp3+ 
Treg cells and their cytokine activity within the infected popliteal lymph nodes to be 
determined. Following L. major infection, the frequency of  CD4+ Foxp3+ Treg cells infiltrating 
the draining lymph nodes was significantly increased in Foxp3creIL-4Rα-/lox  male mice in 
comparison to IL-4Rα-/lox male mice (Figure 3.9A). CD4+Foxp3+ Treg cell cytokine production 
revealed similar levels of IFN-g expression between Foxp3creIL-4Rα-/lox  male mice and their 
littermate control (Figure 3.9B). In contrast, the frequencies of IL-4, IL-10, and IL-13 
CD4+Foxp3+ Treg cells were significantly increased in Foxp3creIL-4Rα-/lox male mice 
compared to littermate mice (Figure 3.9C, Figure 3.9D and Figure 3.9E).  Infected C57BL/6 
mice displayed lower frequencies of these Type 2 cytokine producing Treg cells (Figure 3.9C,  
Figure 3.9D and Figure 3.9E). Collectively, these results suggest that despite the inability of 
IL-4 and IL-13 to signal to these Treg cells, the deletion of IL-4Rα chain within this cell 
population favours enhanced CD4+Foxp3+ Treg cell recruitment and increased Treg-specific 












Figure 3.8:  Total cells in the lymph node of L. major infected male mice. Experimental male mice 
were subcutaneously infected with 2x106 stationary phase L. major LV39 promastigotes into the left 
hind footpad.  The total number of cells within the popliteal lymph node were quantified following an 
8-week L. major infection of experimental male mice in the left hind footpad. Results are representative 
of two independent experiments with 5 mice per group expressed as mean±SEM. Statistical significance 















Figure 3.9: Depletion of IL-4Rα signalling on Foxp3+ Treg cells alters Treg cell frequency and 
activity. Experimental male mice were subcutaneously infected in the left hind footpad with 2x106 
stationary phase L. major LV39 promastigotes for 8 weeks. The frequency of CD4+ Foxp3+ T regulatory 
cells within the popliteal lymph nodes (A) were assessed by flow cytometry analysis. The frequency of  
CD4+ Foxp3+ Treg cells producing IFN-g (B), IL-4 (C), IL-13 (D) and IL-10 (E) were determined by 
flow cytometry analysis Results are representative of two independent experiments with 5 mice per 
group expressed as mean±SEM. Statistical significance was determined in comparison to IL-4Rα-/lox 
mice (*, p≤0.05). 
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3.3.3 Immunological responses observed at the molecular level 
The activation of a Type 2 immune response has been associated with increased susceptibility 
to L. major induced cutaneous leishmaniasis, while induction of Type 1 immune response 
provides the host with protection against L. major infection [9, 11]. In order to determine 
whether the hypersusceptible phenotype observed in Foxp3creIL-4Rα-/lox male was associated 
with an altered immune response, the cytokine and humoral  Type 1 or Type 2 immune 
responses were assessed following L. major infection. Cytokine production was measured 
within infected supernatants following T cell mitogenic (anti-CD3) re-stimulation of total 
lymph node cells at 8 weeks post infection [25].  Similar concentrations of IFN-γ where 
secreted between Foxp3creIL-4Rα-/lox mice and their littermate control IL-4Rα-/lox mice (Figure 
3.10A); while resistant C57BL/6 mice, similar to previous studies, secreted significantly higher 
levels of this Type 1 cytokine [21, 25]. In contrast, the levels of Type 2 cytokine IL-4 were 
significantly higher in Foxp3creIL-4Rα-/lox mice compared to their littermate controls (Figure 
3.10B). Due to the suppressive activity of CD25+ Treg cells being attributed to the secretion of 
IL-10 and TGF-b [103], and the contribution of IL-10 towards the activation of a Type 2 
immune response [104], the concentrations of these cytokines were measured. The levels of 
IL-10 and TGF-b secretion were found to be 2.5 fold greater in the Foxp3creIL-4Rα-/lox mice 
relative to littermate controls (Figure 3.10, C-D). Thus, the deletion of IL-4Rα signalling on 
Treg cells resulted in the elevated production of Type 2 cytokines (IL-4, IL-10) and cytokines 
associated with increased Treg cell suppression (IL-10 and TGF-b), while Type 1 cytokine 





















Figure 3.10: Enhanced Type 2 cytokine secretion occurs in Foxp3creIL-4Rα-/lox mice following L. 
major LV39 infection in the footpad. Experimental male mice were subcutaneously infected in the 
left hind footpad with 2x106 stationary phase L. major LV39 promastigotes. At 8 weeks post infection, 
popliteal lymph node cells were re-stimulated for 72 hours with anti-CD3. IFN-γ (A), IL-4 (B), IL-10 
(C) and TGF-b (D) cytokine production within lymph node cell supernatants was measured by cytokine 
ELISA. Results are representative of two independent experiments with 5 mice per group expressed as 
mean±SEM. Statistical significance was determined in comparison to IL-4Rα-/lox mice (*, p≤0.05; **, 
p≤0.01; ***, p≤0.001). 
The observed shift towards the activation of a Type 2 immune response in Foxp3creIL-4Rα-/lox 
mice was further evaluated by assessing the antibody responses within serum samples 
following 8 weeks of L. major infection. The sera of C57BL/6 mice displayed lower levels of 
Type 1 antibodies (antigen-specific IgG2b) and Type 2 antibodies (antigen-specific IgG1 and 
Total IgE) (Figure 3.11, A-C), similar to previous results, as by 8 weeks post infection 
C57BL/6 mice had healed from L. major infection [25]. In contrast, Foxp3creIL-4Rα-/lox mice 
displayed significantly elevated concentrations of total IgE (Figure 3.11C), indicating 
augmentation towards a Type 2 humoral response, however antigen-specific IgG1 levels were 
similar in comparison to littermate control IL-4Rα-/lox mice (Figure 3.11B). Therefore, the 
deletion of IL-4Rα signalling on Treg cells resulted in isotype switching in B cells, leading to 








































































































































Figure 3.11: Foxp3creIL-4Rα-/lox male mice display an elevated Type 2 humoral response following 
L. major LV39 footpad infection. Experimental male mice were subcutaneously infected in the left 
hind footpad with 2x106 stationary phase L. major LV39 promastigotes. At 8 weeks post infection L. 
major antigen-specific IgG2b (A), IgG1 (B), and total IgE (C) antibody production within infected sera 
were quantified by ELISA. Results are representative of two independent experiments with 5 mice per 
group expressed as mean±SEM. Statistical significance was determined in comparison to IL-4Rα-/lox 
mice (*, p≤0.05; **, p≤0.01; ***, p≤0.001, **** p≤0.0001). 
The augmentation towards a Type 2 immune response within Foxp3creIL-4Rα-/lox mice during 
L. major infection, was further evaluated through the production of nitrite and urea. Previous 
studies have shown that iNOS mediated nitrite production by M1 macrophages induces a Type 
1 killer-effector mechanism that eliminates L. major parasites; in contrast M2 macrophage 
secretion of Arg1 resulted in urea production that induces a Type 2 immune response that 
sustains L. major parasite persistence [24]. The expression of these enzymes from M1 and M2 
macrophages was determined by iNOS and arginase assays executed on LPS stimulated lymph 
nodes. At 8 weeks post infection, similar levels of nitrite production (Figure 3.12A) were 
observed between Foxp3creIL-4Rα-/lox male mice in comparison to littermate control IL-4Rα-
/lox mice. Notably, a significant increase in urea production (Figure 3.12B) was observed in 
Foxp3creIL-4Rα-/lox male mice, indicating that deletion of IL-4Rα signalling on Treg cells 
leading to an increase in M2 macrophage Arg1 activity associated with activation of a Type 2 
immune response, which may have contributed to sustained L. major parasite persistence. 
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Collectively, these results demonstrated that Foxp3creIL-4Rα-/lox mice display preferential 
activation of a Type 2 immune response which accounted for sustained L. major parasite 
replication and led to the hypersusceptible phenotype observed following subcutaneous 















Figure 3.12: Foxp3creIL-4Rα-/lox male mice display modulated killer-effector functions following 
L. major LV39 footpad infection. Experimental male mice were subcutaneously infected in the left 
hind footpad with 2x106 stationary phase L. major LV39 promastigotes. At 8 weeks post infection 
lymph node cells were re-stimulated with 10 ng/ml LPS for 72 hours. Nitrite production (A) in cell 
supernatants were measured by Griess assay and urea production (B) in cell lysates were measured by 
Arginase activity assay. Results are representative of one independent experiment with 5 mice per group 


































































3.4  An alternative infection route results in a similar disease outcome following L. major 
infection in experimental mice 
3.4.1 Deletion of IL-4Rα signalling on T regulatory cells renders BALB/c male mice 
similarly hypersusceptible following inoculation of L. major parasites in the ear 
Previous studies in murine models have provided significant evidence that suggests that 
alternatives routes of L. major infection may lead to differential immune response outcomes 
[94, 105]. Initially, the high parasite dose (105-107) subcutaneous inoculation of the footpad 
was used to examine response to L. major infection. However recent studies have established 
that the intradermal infection of the pinna of the ear with a lower dose of parasites (102-104) 
provides a more physiologically relevant infection model, as it mimics the low dose inoculation 
that occurs at the dermal site by an infected sandfly during natural transmission [94, 106].  To 
determine whether using an alternative route of infection and parasite dose would alter the 
observed phenotype and associated immune responses of Foxp3creIL-4Rα-/lox mice, 
experimental mice were intradermally inoculated with 1x104 L. major promastigotes in the left 
ear. Similar to previous studies [42, 107], C57BL6 mice had significantly reduced ear swellings 
(Figure 3.13A) accompanied with reduced parasite burdens in the ears (Figure 3.13B) and 
cervical lymph nodes (Figure 3.13C), in comparison to IL-4Rα-/lox mice, following L. major 
LV39 infection.  Notably during intradermal L. major ear inoculation Foxp3creIL-4Rα-/lox male 
mice developed significantly increased ear swellings and greater parasite burdens were 
observed in the ear and cervical lymph node, compared to littermate control IL-4Rα-/lox male 
mice (Figure 3.13, A-C). These data suggest that similar to the hypersusceptible phenotype 
observed using the subcutaneous route of infection in the footpad, intradermal ear inoculation 















Figure 3.13: Foxp3creIL-4Rα-/lox male mice following L. major LV39 ear inoculation display a 
hypersusceptible phenotype. Experimental male mice were intradermally inoculated in the left ear 
with 1x104 stationary phase L. major LV39 promastigotes. Changes in diameter at the site of infection 
was measured weekly as ear swelling (mm) (A). Necrosis is indicated by “N” per number of mice in 
which it was observed. At 8 weeks post infection, the parasite burden (2n) within infected ears (B) and 
lymph nodes (C) was determined by limiting dilution assay. The limit of detection (2n) is indicated as 
a dashed line. Results are representative of one independent experiment with 6 mice per group expressed 
as  mean±SEM. Statistical significance was determined in comparison to IL-4Rα-/lox mice (*, p≤0.05; 
**, p≤0.01; ***, p≤0.001, **** p≤0.0001). 
 
3.4.2 Cytokine and antibody responses elicited in Foxp3creIL-4Rα-/lox male mice during L. 
major ear infection 
 
Following 8 weeks of L. major infection, cytokine production within infected lymph node 
supernatants and antibody titres from sera samples were measured by ELISA. Although 
statistical significance was not observed, the biological concentrations of Type 2 cytokines IL-
4 (Figure 3.14A) and IL-10 (Figure 3.14B) were greater in Foxp3creIL-4Rα-/lox male mice 
compared to littermate control IL-4Rα-/lox mice following intradermal ear infection. Similar to 
antibody titre production observed during subcutaneous footpad infection (Figure 3.11C), 
Foxp3creIL-4Rα-/lox male mice produced significantly greater total IgE levels (Figure 3.14C) in 
comparison to littermate control IL-4Rα-/lox mice. Collectively, these data suggest that despite 
changing the route of infection, the intradermal infection route in the ear results in a similar 
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Figure 3.14:  Similar Type 2 immunity is enhanced in Foxp3creIL-4Rα-/lox male mice following ear 
inoculation with L. major LV39 promastigotes. Experimental male mice were intradermally 
inoculated in the left ear with 1x104 stationary phase L. major LV39 promastigotes. At 8 weeks post 
infection, cervical lymph node cells were re-stimulated for 72 hours with anti-CD3. The production of 
IL-4 (A) and IL-10 (B) within lymph node cell supernatants were measured by ELISA. At 8 weeks post 
infection total IgE (C) antibody production within infected sera were quantified by ELISA. Results are 
representative of one independent experiment with 6 mice per group expressed as  mean±SEM. 
Statistical significance was determined in comparison to IL-4Rα-/lox mice (*, p≤0.05; **, p≤0.01; ***, 
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3.5  Proposed mechanism in hypersusceptible L. major-infected Foxp3creIL-4Rα-/lox male 
mice 
 
3.5.1 Enhanced IDO expression from dendritic cells is found in L. major-infected 
Foxp3creIL-4Rα-/lox male mice 
 
Previous studies have found that L. major parasites enhance the expression of an Indoleamine 
2,3 dioxygenase (IDO) from dendritic cells to allow for successful replication within the 
infected host [108, 109]. IDO expression has further been shown to activate Treg cell activity 
by cell-mediated interactions via the B7 (CD80/86)/CTLA-4 or PD-L1/PD-1 pathways [110, 
111]. Given the increased parasite burdens observed in L. major-infected Foxp3creIL-4Rα-/lox 
male mice (Figures 3.6, D-F, Figure 3.7B and Figure 3.13, B-C), we decided to examine 
whether elevated IDO expression contributed to the hypersusceptible phenotype observed in 
this model. The gating of various dendritic cell subpopulations by flow cytometry allowed for 
the expression of IDO, PD-L1 and CD80 to be assessed at a protein level (Supplementary 
Figure 4). Under naïve conditions, conventional dendritic cells (cDCs) and plasmacytoid 
dendritic cells (pDCs) within popliteal lymph nodes from Foxp3creIL-4Rα-/lox male mice and 
their L-4Rα-/lox littermate control had comparable levels of IDO GMFI expression  
(Supplementary Figure 5, A-B). Similarly, there were no differences in frequencies of IDO+, 
PD-L1+, CD80+ cDCs and IDO+, PD-L1+, CD80+ pDCs within popliteal lymph nodes from 
Foxp3creIL-4Rα-/lox male mice and their littermate controls (Supplementary Figure 5C). 
Following 8 weeks of L. major infection, cDCs and pDCS with popliteal lymph nodes from 
Foxp3creIL-4Rα-/lox male mice showed significantly elevated IDO expression compared to L-
4Rα-/lox littermate control mice (Figure 3.15, A-B). The frequencies of IDO+, PD-L1+, CD80+ 
cDCs and IDO+, PD-L1+, CD80+ pDCs infiltrating the draining lymph nodes was significantly 
higher in Foxp3creIL-4Rα-/lox  male mice in comparison to IL-4Rα-/lox male mice (Figure 3.15C). 
These results suggest that within Foxp3creIL-4Rα-/lox  male IDO expressing dendritic cells are 












































Figure 3.15: Dendritic cell populations within Foxp3creIL-4Rα-/lox mice show upregulated IDO, 
PDL-1 and CD80 expression following L. major infection. Foxp3creIL-4Rα-/lox and littermate control 
mice were infected subcutaneously with 2×106 stationary phase L. major LV39 promastigotes into the 
left hind footpad. At 8 weeks post infection, geometric mean fluorescent intensity (GMFI) of IDO 
expression was determined by flow cytometry analysis from the popliteal lymph nodes of L. major-
infected IL-4Rα-/lox and Foxp3creIL-4Rα-/lox male mice. (A) IDO GMFI in conventional dendritic cells 
(cDCs; CD19-CD11b+CD11c+MHCII+), (B) IDO GMFI in plasmacytoid DCs (pDCs; 
CD11c+MHCII+B220+), (C) Frequency of IDO expressing, PD-L1 and CD80 expressing dendritic cell 
subpopulations from the popliteal lymph nodes of IL-4Rα-/lox and Foxp3creIL-4Rα-/lox male mice 
following L. major infection.  The following analyses are representative of 1 independent experiment  
with 5 mice per group expressed as mean±SEM. Statistical significance was determined in comparison 




























































































































































3.5.2 PD-1 expression on Foxp3+ Treg cells is enhanced in L. major-infected Foxp3creIL-
4Rα-/lox male mice 
 
Previous studies have shown that during antigen presentation IDO expression in dendritic cells 
activates the PD-L1 or CD80/CD86 molecules that in turn ligate to the PD-1 or CTLA-4 
molecules on Treg cells, activating their suppressive activity [82, 110, 112]. Given that in L. 
major-infected Foxp3creIL-4Rα-/lox male mice dendritic cells displayed elevated IDO levels 
associated with increased PD-L1 and CD80/CD86 expression (Figure 3.14, A-C and Figure 
3.15, A-C), the expression of PD-1 on Treg cells was subsequently evaluated by flow 
cytometry analysis. Unfortunately at the time of the experiment, a fluorescently conjugated 
anti-CTLA-4 antibody was unavailable and therefore the expression of CTLA-4 on Treg cells 
could not be evaluated. The gating of CD4+Foxp3+ Treg cells by flow cytometry allowed for 
expression of PD-1 to be assessed (Supplementary Figure 6). Under naïve conditions, 
comparable PD-1 GMFI on CD4+ Foxp3+ Treg cells and frequency of PD-1+ Treg cells were 
observed between Foxp3creIL-4Rα-/lox male mice and their IL-4Rα-/lox littermate control 
(Supplementary Figure 7, A-B). Notably following 8 weeks of L. major infection,  the 
frequency of PD-1+ CD4+ Foxp3+ Treg cells infiltrating the draining lymph nodes significantly 
increased in Foxp3creIL-4Rα-/lox  male mice in comparison to IL-4Rα-/lox male mice (Figure 
3.16A). Furthermore, Foxp3creIL-4Rα-/lox male mice had significantly increased PD-1 GMFI 
expression, in comparison to L-4Rα-/lox littermate controls (Figure 3.16B). These results 
suggest that within Foxp3creIL-4Rα-/lox  male mice IDO+ dendritic cells and Treg cell interact 





























Figure 3.16: Deletion of IL-4Rα on Treg cells upregulates PD-1 expression following L. major 
infection. Foxp3creIL-4Rα-/lox and littermate control mice were infected subcutaneously with 2×106 
stationary phase L. major LV39 promastigotes into the left hind footpad. (A) The frequency of PD-1 
expressing T cells in the popliteal lymph node at 8 weeks post L. major infection. (B) PD-1 GMFI in 
CD4+Foxp3+ Treg cells in the popliteal lymph node at 8 weeks post L. major infection. The following 
analyses are representative of 1 independent experiment with 5 mice per group expressed as 
mean±SEM. Statistical significance was determined in comparison to IL-4Rα-/lox mice (*, p≤0.05; **, 
p≤0.01). 
 
3.5.3 Differential IDO expression within L. major-infected Foxp3creIL-4Rα-/lox male mice 
could account for reduced T-bet+ Th1 cell recruitment 
 
Along with its role in activating Treg cell activity, previous studies have shown that IDO 
oxidation of L-tryptophan along the kynurenine pathway produced metabolites that induced T-
cell apoptosis, specifically downregulating Th1 cells [83, 113]. Given that dendritic cells 
expressed elevated IDO levels within L. major-infected Foxp3creIL-4Rα-/lox male mice (Figure 
3.15, A-C), we next examined by intranuclear staining the recruitment of transcription factor 
expressing T cell subsets. Following L. major infection, the frequencies of CD4+ GATA3+ Th2 
cells and CD4+RORgt Th17 cells infiltrating the popliteal lymph nodes was comparable 
between Foxp3creIL-4Rα-/lox  male mice and their littermate controls (Figure 3.17). Similar to 
the results in Figure 3.9A, a significantly greater frequency of CD4+Foxp3+ Treg cell infiltrated 
the draining lymph nodes in Foxp3creIL-4Rα-/lox  male mice (Figure 3.17). Notably, the 
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reduced in Foxp3creIL-4Rα-/lox  male mice in comparison to their littermate controls (Figure 
3.17). These data provide supporting evidence that supports a mechanism whereby L. major 
parasites enhancing dendritic cell mediated IDO expression within infected Foxp3creIL-4Rα-
/lox  male mice, concomitantly resulted in increased Treg cell activity and increased selective 
























Figure 3.17: Deletion of IL-4Rα signalling on Treg cells enhances recruitment of Foxp3+ Treg cells 
and reduces recruitment of T-bet+ Th1 cells following L. major infection. Foxp3creIL-4Rα-/lox and 
littermate control mice were infected subcutaneously with 2×106 stationary phase L. major LV39 
promastigotes into the left hind footpad. (A) The frequency of transcription factor expressing 
CD3+CD4+ T cells in the popliteal lymph node at 8 weeks post L. major infection. The following 
analyses are representative of 1 independent experiment with 5 mice per group expressed as 




































































The ability of L. major parasites to persistent within a mammalian host is primarily based on 
immune response polarization in response to infection. Given that currently there are no 
commercially available vaccines against cutaneous leishmaniasis, the use of experimental 
murine models has been utilized as a robust system to elucidate the immune evasion strategies 
utilized by Leishmania parasites in order to identify novel immunotherapeutic targets for 
effective disease management [114]. During the first 72 hours post L. major infection, the 
decision between mounting a protective Type 1 immune response or susceptible Type 2 
immune response occurs [115]. 
IL-4 and IL-13 were initially identified as canonical cytokines in initiating a Type 2 immune 
response during L. major infection,  as its early secretion by Vβ4+ Vα8+ CD4+ T cells caused 
elevated Th2 cell development and downregulated the secretion of Th1 cytokines IFN-g and 
IL-12, resulting in enhanced susceptibility to L. major infection [25, 32]. Given the key roles 
of IL-4 and IL-13 in modulating Type 2 immune response, the impact of signalling via their 
common IL-4Rα chain was further examined.  
As the IL-4Rα chain is ubiquitously expressed on an array of immune cells including 
keratinocytes, macrophages, dendritic cells, B cells and T cells, various cell-specific IL-4Rα 
deficient murine models have been established using the cre/loxP system to investigate IL-4Rα 
signalling on specific cell populations [26, 31]. The use of cell-specific IL-4Rα-deficient 
murine models during L. major infection has provided novel roles on specific cell populations 
through which IL-4Rα signalling has a detrimental effect leading to sustained parasite 
persistence or  IL-4Rα signalling induces a protective effect leading to a reduction in parasite 
survival. In murine models IL-4Rα signalling on neutrophils, macrophages, B cells and total T 
cells were shown to favour L. major replication [45, 55, 59, 60]. In contrast, IL-4Rα signalling 
on dendritic cells was shown to be required to initiate NO-driven killer effector mechanism 
that reduces L. major survival within an infected host [6]. 
Foxp3+ Treg cells are a unique CD4+ T cell subset whose immunosuppressive activities are 
crucial for maintaining homeostasis between Type 1 or Type 2 immune responses and tolerance 
to self-antigens [61, 84]. IL-4 signalling has been shown to have both inhibitory and 
stimulatory effects on Treg cell development [36, 93].  
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During L. major infection, aggregation of CD4+CD25+ Treg cells at the site of infection has 
been found to have a detrimental effect, as they inhibit effector T cells ability to control parasite 
replication [87, 88]. In contrast, Treg cells have been shown to have a protective role in host 
immunity as they inhibit early IL-4 production in BALB/c mice, thereby reducing activation 
of a Type 2 immune response and allowing for L. major survival [20].  
Treg cells therefore appear to contribute to host protection against and lead to sustained L. 
major replication at the site of infection, indicating that for effective protection against L. major 
infection a balance is required between Treg cells and effector T cells [20, 84, 87]. Given their 
critical role in regulating host immunity and the apparent dual roles of  IL-4 signalling in their 
development, Treg cells have provided a novel CD4+ T cell population in which to explore 
further. In this study, Treg cell-specific (Foxp3creIL-4Rα-/lox) BALB/c mice generated using the 
cre/loxP system[89] were utilized to investigate whether IL-4Rα signalling on Treg cells 
influences disease outcome during cutaneous leishmaniasis.  
 
Following L. major LV39 infection Foxp3creIL-4Rα-/lox mice were found to have depletion of 
the IL-4Rα chain specifically on CD4+ Foxp3+ Treg cells, while IL-4Rα expression was 
maintained in other cell populations. In naïve Foxp3creIL-4Rα-/lox mice, Cre-mediated deletion 
on Treg cells resulted in the partial deletion of the IL-4Rα chain in females and a quasi-
complete deletion of the IL-4Rα chain in males [89]; this may have occurred as a result of 
random inactivation of genes along the X chromosome that occurs within females only [116]. 
During this study, it was determined that the differential deletion efficiency of the IL-4Rα chain 
on Treg cells observed between  Foxp3creIL-4Rα-/lox female and male mice was conserved 
during L. major infection. 
 
A previous study showed that specific deletion of the IL-4Rα chain on Foxp3+ Treg cells 
resulted in mice developing enhanced tissue inflammation during Schistosoma mansoni and 
Nippostrongylus brasiliensis infections [89]; however the effects during cutaneous 
leishmaniasis were unknown. 
 
In order to determine the role of IL-4Rα signalling on Foxp3 disease outcome during cutaneous 
leishmaniasis, Foxp3creIL-4Rα-/lox female and male mice were infected with L. major LV39 
promastigotes subcutaneously in the footpad. Infection of Foxp3creIL-4Rα-/lox female with L. 
major promastigotes revealed similar footpad swellings, accompanied with similar parasite 
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burdens in the footpads, popliteal lymph nodes and spleens in comparison to IL-4Rα-/lox female  
littermate controls. In contrast, L. major infection of  Foxp3creIL-4Rα-/lox male mice revealed a 
protective role for IL-4Rα signalling on Treg cells in controlling L. major disease progression. 
In comparison to IL-4Rα-/lox male littermate controls, Foxp3creIL-4Rα-/lox male mice developed 
greater footpad swellings and earlier necrosis. The hypersusceptible phenotype observed in 
Foxp3creIL-4Rα-/lox male mice was associated with significantly greater parasite loads which 
were analysed using LDA and endpoint PCR techniques.  The endpoint PCR technique was 
utilised to quantify amastigote kDNA levels within infected footpad samples, however viable 
and non-viable parasites cannot be distinguished using this technique, so the results were 
compared to the LDA technique which allowed for the quantification of viable parasites within 
infected tissues following transformation from amastigote form within a mammalian host to in 
vitro promastigote form [25, 95]. Foxp3creIL-4Rα-/lox male mice developed significantly greater 
parasite burdens in the infected footpads, popliteal lymph nodes and spleens as well as 
significantly enhanced relative amastigote kDNA expression levels in comparison to IL-4Rα-
/lox male littermate controls. In line with previous studies, genetically resistant C57BL/6 mice 
showed reduced footpad swelling and parasite burdens in the footpads and popliteal lymph 
nodes indicating effective control of L. major infection [25, 26]. Collectively, the difference in 
phenotype observed between Foxp3creIL-4Rα-/lox female and male suggests that a greater IL- 
IL-4Rα deletion efficiency on Treg cells enhances susceptibility of the Foxp3creIL-4Rα-/lox 
murine strain to L. major infection.  
Foxp3+ T reg cells are able to maintain immune homeostasis by modulating cytokine 
production [65]. Flow cytometry analysis revealed significantly greater frequencies of 
CD4+Foxp3+ Treg cell which produced IL-4, IL-10 or IL-13 were recruited in Foxp3creIL-4Rα-
/lox  male mice compared to their IL-4Rα-/lox littermate controls (Figure 4.1); which suggests 
that deletion of the IL-4Rα signalling on Treg cells augments these cells to increase Type 2 
cytokine production during L. major infection. The increased CD4+Foxp3+ Treg cell 
frequencies observed in L. major-infected Foxp3creIL-4Rα-/lox  male mice were in line with a 
previous study that also showed increased CD4+Foxp3+ Treg cell frequencies in the ear dermis 
of L. major-infected IL-4Rα-/- BALB/c mice [117]; which suggests that a global deletion or 
Treg cell specific deletion of IL-4Rα signalling in BALB/c mice results in a similar increase in 
CD4+Foxp3+ Treg cell recruitment during L. major infection. 
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The results of this study support a previous study that suggested IL-4 signalling via STAT6 
was required to maintain to Foxp3 expression in CD4+CD25+ Treg cells [36], as despite 
deletion of IL-4 signalling via the IL-4Rα chain, CD4+Foxp3+ Treg cell were able to increase 
IL-4 production which had a stimulatory effect on Treg cell differentiation.   
Previous studies have determined that activation of Type 1 immune response within an infected 
mammalian host is detrimental to L. major survival, while induction of Type 2 immune 
response is favourable for L. major persistence [9, 39]. To determine the type of immune 
response elicited as a result of deleting the IL-4Rα chain on Treg cells, cytokine and antibody 
levels were compared following subcutaneous L. major infection. Treg cells secretion of 
suppressive cytokines, IL-10 and TGF-b has been shown to inhibit Th1 cell and Th2 cell 
activity and inhibit macrophages ability to kill intracellular Leishmania parasites [103, 118]. 
Analysis of T-cell specific cytokine production in Foxp3creIL-4Rα-/lox male mice revealed 
elevated production of IL-4, IL-10 and TGF-b, which suggested that increased Th2 and Treg 
cell cytokine activity contributes to the hypersusceptible phenotype observed during L. major 
infection (Figure 4.1). 
 
Analysis of antibody production by B cells in Foxp3creIL-4Rα-/lox male mice showed 
significantly increased total IgE levels, accompanied with increased  IL-4 and IL-10 secretion, 
indicated the shift towards an elevated Type 2 immune response occurred followed L. major 
footpad infection (Figure 4.1). Notably comparable of levels of SLA-specific IgG1, another 
Type 2 antibody, were detected within Foxp3creIL-4Rα-/lox male mice and their IL-4Rα-/lox 
littermate controls. Meiler et al. (2008) showed that increased IL-4 levels induce class-
switching in B cells to enhance IgE production [119], which could account for the specific 
elevated levels of IgE detected in Foxp3creIL-4Rα-/lox male mice following L. major infection. 
During L. major infection activation of a Type 1 immune response results in activation of M1 
macrophages and leads to the destruction of intracellular Leishmania parasites by iNOS 
production [11].  The initiation of a Type 2 immune response enhances Leishmania survival as 
Th2 cells secretion of IL-4, IL-13 and IL-10 activate M2 macrophages to secrete Arginase 1 
that depletes the common L-arginine substrate thereby subverting the NO-driven killer effector 
mechanism and allowing for L. major replication [9, 24]. The augmentation towards a Type 2 
immune response within Foxp3creIL-4Rα-/lox mice during L. major infection was further 
examined by iNOS and Arg1 activity.  Following L. major footpad infection, similar expression 
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of iNOS was detected, indicated by comparable nitrite production levels, between Foxp3creIL-
4Rα-/lox male mice and their  IL-4Rα-/lox littermate controls. In contrast,  the significant increase 
in Arg1 activity indicated by increased urea production observed in Foxp3creIL-4Rα-/lox mice,  
indicated a shift towards M2 macrophage activation probably as a result of increased IL-4 and 
IL-10 production (Figure 4.1). 
Previous studies in murine models have provided significant evidence that suggests that 
alternatives routes of L. major infection may lead to differential immune response outcomes 
[94, 105].  The subcutaneous footpad route of infection has been shown to require a high 
parasite dose (105-107) to induce L. major persistence within BALB/c mice; while the 
intradermal ear route of infection has provided an effective alternative model as it mimics 
natural sandfly infection with a lower parasite dose (102-104) [94, 120].  Similar to a previous 
study genetically resistant C57BL/6 mice developed reduced ear swellings and decreased 
parasite burden following L. major ear inoculation [42]. Foxp3creIL-4Rα-/lox male mice 
inoculated with 1x104 L. major promastigotes developed significantly increased ear swellings 
and parasite burdens, associated with elevated IL-4, IL-10 and total IgE levels, compared to 
their IL-4Rα-/lox littermate controls (Figure 4.1). These results suggested that both the 
subcutaneous footpad and intradermal ear routes of infections led to the induction of a Type 2 
immune response that contributed towards the hypersusceptible phenotype observed in 
Foxp3creIL-4Rα-/lox male mice following L. major infection. 
Collectively, these data suggest that efficient deletion of  IL-4Rα signalling on Treg cells 
renders BALB/c mice hypersusceptible to L. major infection associated with augmentation 































Figure 4.1 Deletion of the IL-4Rα chain on Foxp3+ Treg cells induces a Type 2 immune response 




 BALB/c male mice, deletion of the IL-4R⍺ 
signalling on CD4+ Foxp3+  Treg cells primes, through cytokine signalling, the differentiation of naïve 
T cells into Treg cells. This resulted in increased production of Th2 and Treg cytokines (IL-4, IL-10, 
IL-13 and TGF-β). Elevated IL-4 levels can induce Th2 cell differentiation, direct M2 macrophage 
activation which leads to increased Arg1 activity and class switching of B cells to favour IgE antibody 
production; this apparent shift towards a Type 2 immune response favours L. major replication. 
 
 
This current study has provided an additional host immune cell population in which IL-4Rα 
signalling has a protective role against L. major infection. Contrary to other L. major-infected 
cell-specific IL-4Rα conditional knockout models that developed a resistant phenotype [45, 55, 
59], deletion of IL-4Rα signalling on dendritic cells [6] and Treg cells lead to BALB/c mice 
developing a hypersusceptible phenotype. A previous study showed IL-4Rα-/- BALB/c mice 
were only able to control acute L. major infection for 80 days, then they succumbed to infection 
[25]; suggesting that the deletion of IL-4Rα signalling on a particular subset of host cells may 





























that signal exists between dendritic cells and Treg cells, through which IL-4Rα signalling has 
a protective role against L. major infection. 
 
IDO is an immunosuppressive enzyme primarily expressed by dendritic cells that has been 
shown to promote Treg cell differentiation and maintain Treg cell suppressive activity [83, 
111]. IDO expression by dendritic cells has shown to promote Treg cell suppressive activity 
by CD80/86 or PD-L1 ligating to CTLA-4 or PD-1 respectively on Treg cells [82]. 
 
A previous study showed that to prevent against lethality during Schistosoma mansoni infection 
IL-4Rα-/- mice induced elevated IDO levels within the liver and intestine [121]; which proposed 
a link between IL-4Rα signalling and IDO expression. Makala et al. (2001) showed that  IDO-
/- mice had significantly reduced footpad swellings and footpad parasite burdens following L. 
major infection, which suggested that L. major parasites enhance IDO expression within an 
infected host to enhance their survival [108]. Flow cytometry analysis was utilised to determine 
whether the hypersusceptible phenotype observed in L. major-infected Foxp3creIL-4Rα,/lox 
male mice was driven by potential IDO-mediated mechanism. 
 
Previous studies had suggested that the dendritic cell subset that expressed the greater level of 
IDO were pDCs (CD11c+MHCII+B220+) [108, 122]. Increased frequencies of IDO+, PD-L1+, 
CD80+ cDCs and IDO+, PD-L1+, CD80+ pDCs infiltrated the popliteal lymph nodes 
Foxp3creIL-4Rα-/lox  male mice during L. major infection; this suggested that the increased IDO 
expression observed was associated with up-regulation of PD-L1 molecules on activated 
dendritic cells. This observed elevated IDO expression within L. major-infected Foxp3creIL-
4Rα-/lox  male mice was associated with elevated PD-1 expression on Treg cells specifically; 
which correlated with increased Treg cell recruitment and secretion of Treg cell cytokines IL-
10 and TGF-b. In the future, CTLA-4 expression will be examined at a protein level by flow 
cytometry analysis to examine whether CTLA-4/CD80 pathway is also activated. These results 
supported a hypothesis proposed in a previous study that suggests that elevated PD-L1/PD-1 
engagement induces the expression of IDO by dendritic cells which in turn inhibits the 
mTOR/Akt pathway that destabilizes Treg cell function, allowing Treg cells to maintain their 
suppressive activity [111].  
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Previous studies have shown that increased IDO production leads to an accumulation of 
tryptophan metabolites such as kynurenine, quinolinic acid and picolinic acid, which induce 
apoptosis in CD4+ Th1 cells and have no effect on Th2 cells [83, 113]. In vitro analysis revealed 
that increased IDO production prevents the conversion of Treg cells to Rorgt+ Th17-like cells 
[123].  To determine whether the observed increase in IDO production observed in  L. major-
infected Foxp3creIL-4Rα-/lox male mice affected CD4+ T cell differentiation, transcription-
factor expressing CD4+ T cells were stained intranuclearly. A significant decrease in the 
frequency of CD4+T-bet+ Th1 cells was observed while the frequencies of CD4+GATA3+ Th2 
cells and CD4+Rorgt+ Th17 cells recruited to the popliteal lymph nodes remained unchanged 
in L. major-infected Foxp3creIL-4Rα-/lox male mice; which may suggest that observed increase 
in IDO production observed Foxp3creIL-4Rα-/lox male mice may reduce Th1 cell recruitment 
while simultaneously preventing the conversion of Treg cells into Th17,  which in turn favours 
activation of Type 2 immune response.   
 
Collectively, the results from this study suggest that deletion of IL-4Rα signalling on Treg cells 
in BALB/C mice lead to L. major parasites increasing IDO expression from dendritic cells, 
which in turn upregulates PD-L1 molecule to ligate to PD-1 on Treg cells, resulting in increased 
Treg cell activity (Figure 4.2). Concomitantly, increased IDO expression may have reduced 
Th1 cell recruitment at the site of infection (Figure 4.2), which in turn allowed for the induction 
of an elevated Type 2 immune response that favours L. major replication.  
 
In order to validate whether the proposed mechanism outlined by the data from L. major-
infected Foxp3creIL-4Rα-/lox male mice has translational potential, further studies will need to 
be conducted in cutaneous leishmaniasis diagnosed human patients. In a previous study qRT-
PCR analysis on RNA extracted from human skin biopsies have shown significant increases in 
FOXP3 expression and elevated IDO expression in L. vianna-infected patients  diagnosed with  
chronic cutaneous leishmaniasis as compared to asymptotically infected individuals [124]. 
Immunohistochemical analysis of stained human skin biopsies revealed higher intensities of 
Foxp3 expression in L. brazilensis-infected patients diagnosed with cutaneous leishmaniasis 
compared to healthy controls [84]. In the future, in line with these previous experiments, we 
would like to conduct immunohistochemistry and extract RNA from  skin lesions of patients 
infected with L. major-causing cutaneous leishmaniasis and conduct qRT-PCR to analyse 
whether there is differential expression of IL-4Rα, FOXP3 and IDO; which may provide a 
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novel mechanism to explain sustained Leishmania replication and lesion development in 
human patients. 
 
A previous study has identified that human patients diagnosed with chronic dermal 
leishmaniasis, caused by L. vianna, showed a 2-fold increase in CD4+CD25+Foxp3+ Treg cell 
recruitment in peripheral blood-mononuclear samples (PBMCs) [124]. In the future, in line 
with this approach we will analyse via flow cytometry whether PBMCs isolated from L. major-
infected patients display differential CD4+Foxp3+ Treg cell and CD4+T-bet+ Th1 cell 




























































Figure 4.2: Induced IDO production from dendritic cells concomitantly induces Treg cell 
production and reduces Th1 cell activity during L. major infection.  L. major parasites enhance IDO 
production from dendritic cells, which in turn upregulates PD-L1 expression which signals PD-1 
expression on Treg cell and increases Treg cell production. IDO expression from dendritic cells leads 
to the apoptosis of Th1 cells, which in turn favours a Type 2 immune response and leads to increased 





















In conclusion, this study has provided a novel outcome of IL-4Rα signalling on a CD4+ T cell 
subpopulation during cutaneous leishmaniasis. Deletion of the IL-4Rα chain on Foxp3+ Treg 
cells enhanced BALB/c mice susceptibility to L. major infection; This resulted in enhanced 
disease progression and increased parasite dissemination from the infection site, This study has 
further proposed a novel mechanism by which enhanced IDO production within Foxp3creIL-
4Rα-/lox male mice may contribute to the elevated Type 2 immune response induced following 
L. major infection. The protective role of IL-4Rα signalling on Foxp3+ Treg cells during 
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List of Flow Cytometry Antibodies used 
Antibody Company Clone Catalogue 
Number 
Dilution 
CD3 BD Pharmingen 500A2 557984 1:320 
CD4 BD Pharmingen RM4-5 553052 1:640 






PD-1 Biolegend 29F.1A12 135208  1:320 
Ki67 BD Pharmingen B56 51-
36525X 
1:50 
GATA3 BD Pharmingen L50-823 560405 1:40 





RoRγt BD Pharmingen Q31-378 562683 1:40 
Foxp3 BD Pharmingen MF23 560401 1:100 
IFN-γ BD Pharmingen XMG1.2 554412 1:50 
IL-4 BD Pharmingen 11B11 560700 1:50 








CD11c BD Pharmingen HL3 560583 1:320 






B220 BD Horizon RA3-6B2 561226 1:640 
CD80 BD Pharmingen 16-10A1 553769 1:320 
PD-L1 Biolegend 10F.9G2  124311 1:320 
IDO eBioScience mIDO-48 11-9473-
82 
1:100 








List of ELISA Antibodies  
Cytokine 
Antibody 




IL-4 Primary BD Biosciences 11B11 2 µg/ml 
Standard BD Biosciences 550067 100 ng/ml 
Secondary BD Biosciences BVD6-24G2 0.5 µg/ml 
IL-10 Primary WhiteSci MAB417-500 1 µg/ml 
 Standard WhiteSci 417-ML-005 100 ng/ml 
 
 Secondary Biocom Biotech 504906 0.5 µg/ml 
TGF-β Primary BD Biosciences 555052 1:500 
 Standard WhiteSci 240-B-002 100 ng/ml 
 Secondary BD Biosciences 555053 1:250 
IFN-γ Primary Lab-made (UCT) AN18KL6  1 µg/ml 
 Standard BD Biosciences 554587 500 ng/ml 
 




















































Supplementary Figure 1: Gating strategies used to analyse CD19+ B cell, CD4+ Foxp3+ and 
CD4+Foxp3- T cell populations. Experimental mice were subcutaneously infected with 2x106 
stationary phase L. major LV39 promastigotes into the left hind footpad. Popliteal lymph node cells 
were isolated from L. major infected experimental mice, stained and gated for B cell (CD3-CD19+) and 
T cell populations (CD3+CD4+). The Treg cell population was identified as CD4+ Foxp3+. The following 





































































































Supplementary Figure 2: Leishmania parasite DNA is significantly increased in Foxp3creIL-4Rα-
/lox male mice. Experimental mice were subcutaneously infected in the left hind footpad with 2x106 
stationary phase L. major LV39 promastigotes. At 8 weeks post infection, amastigote kinetoplast DNA 
extracted from infected footpads was amplified via PCR with JW11/JW12 primers. The final 120 bp 
PCR products were electrophoresed on 1.5% agarose gels and visualized following ethidium bromide 
staining under UV illumination. (A) Lane 1: 50 bp DNA ladder; Lane 2: L. major in vitro culture; Lanes 
3-7:  Female IL-4Rα-/lox samples; Lanes 8-12; Female  Foxp3creIL-4Rα-/lox samples; Lane 13: Negative 
Control (No DNA). (B) Lane 1: 50bp DNA ladder; Lane 2: L. major in vitro culture; Lanes 3-7:  Female 
C57BL/6 samples; Lane 8: -ve control. (C) Lane 1:  50 bp DNA ladder; Lane 2: L. major in vitro culture; 
Lanes 3-6: Male IL-4Rα-/lox samples; Lanes 7-10: Male Foxp3creIL-4Rα-/lox samples; Lane 11: -ve 
control. (D)  Lane 1: 50bp DNA ladder; Lane 2: L. major in vitro culture; Lanes 3-6:  Male C57BL/6 
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Supplementary Figure 3: Gating strategies used to identify cytokine-producing Treg cell 
populations. Experimental mice were subcutaneously infected with 2x106 stationary phase L. major 
LV39 promastigotes into the left hind footpad. Popliteal lymph node cells were isolated from L. major 
infected experimental mice, stained and gated for Treg cell populations (CD4+Foxp3+). Cytokine 
secreting Treg cells were gated for the production of IFN-g, IL-4, IL-10 and IL-13, within the popliteal 
lymph node following PMA/Ionomycin stimulation in the presence of monensin. The following 






















































































Supplementary Figure 4: Gating strategies used to  CD11c+ dendritic cell populations. 
Experimental mice were subcutaneously infected with 2x106 stationary phase L. major LV39 
promastigotes into the left hind footpad. Popliteal lymph node cells from Foxp3creIL-4Ra and their 
littermate control mice were stained and gated to identify various dendritic cell populations. Dendritic 
cells populations were differentiated according to the following markers: conventional dendritic cells 
(cDCs; CD19-CD11b+CD11c+MHCII+), plasmacytoid DCs (pDCs; CD11c+MHCII+B220+) and 
dendritic cells expressing CD80, PD-L1 and IDO. The following analyses are representative of 1 


































































































































Supplementary Figure 5: Dendritic cell populations expression of IDO and PD-L1 in naïve 
experimental mice. Geometric mean fluorescent intensity (GMFI) of IDO expression was determined 
by flow cytometry analysis from the popliteal lymph nodes of naïve  IL-4Rα-/lox and Foxp3creIL-4Rα-/lox 
male mice. (A) IDO GMFI in conventional dendritic cells (cDCs; CD19-CD11b+CD11c+MHCII+), (B) 
IDO GMFI in plasmacytoid DCs (pDCs; CD11c+MHCII+B220+), (C) Frequency of IDO expressing or 
PD-L1 expressing dendritic cell subpopulations from the popliteal lymph nodes of naïve mice. The 




































































































































































Supplementary Figure 6: Gating strategies used to identify PD-1 expressing Foxp3+ Treg cells 
Experimental mice were subcutaneously infected with 2x106 stationary phase L. major LV39 
promastigotes into the left hind footpad. Popliteal lymph node cells were isolated from Foxp3creIL-4Ra 
and their littermate control mice stained and gated for expression of PD-1 on the Treg cell population 












































































































Supplementary Figure 7: Treg cell population expression of PD-1 in naïve experimental mice. 
Geometric mean fluorescent intensity (GMFI) of PD-L1 expression was determined by flow cytometry 
analysis from the popliteal lymph nodes of naïve IL-4Rα-/lox and Foxp3creIL-4Rα-/lox male mice. (A) PD-
1 GMFI in CD4+Foxp3+ Treg cells (B) Frequency of PD-1 expressing T cell populations from the 
popliteal lymph nodes of naïve mice. The following analyses are representative of 1 independent 























































































































Supplementary Figure 8: Gating strategies used to identify transcription factor expressing T cell 
populations. Experimental mice were subcutaneously infected with 2x106 stationary phase L. major 
LV39 promastigotes into the left hind footpad. Popliteal lymph node cells were isolated from L. major 
infected experimental mice, stained and gated for T cell populations (CD3+CD4+). Treg cells were 
identified as CD4+ Foxp3+, Th17 cells were identified as CD4+RoRgt+, Th1 cells were identified as 
CD4+T-bet+ and Th2 cells were identified as CD4+GATA3+. FMO: Fluorescence minus one. The 
following analyses are representative of 2 independent experiments with 5 mice per group. 
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